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Sommaire 
La maladie pulmonaire obstructive chronique (MPOC) est une maladie respiratoire 
irréversible, évolutive et très fréquente qui fait peser un lourd fardeau sur le système de 
santé, les patients et leurs proches. La réadaptation pulmonaire (RP) est efficace pour 
réduire la dyspnée et l’utilisation des ressources en soins de santé et pour améliorer la 
capacité physique et la qualité de vie des patients. L’entraînement physique est la pierre 
angulaire de la RP, mais elle n’est bénéfique que si les patients 1) assistent aux séances 
d’exercice, 2) se conforment à l'intensité des exercices prescrits et 3) maintiennent 
l'exercice physique régulier après la RP. La dépression comorbide est disproportionnée 
dans la MPOC et s’est révélée être un facteur prédictif de « mauvaise » fréquentation de 
la RP, et d'abandon de la pratique physique régulière après le programme. À notre 
connaissance, aucune étude ne s'est intéressée aux prédicteurs de conformité à l'intensité 
d'exercice prescrit pendant la RP et seules quelques études ont explorées les facteurs 
associés au maintien de l'exercice après la RP. L’objectif principal de cette étude consistait 
à examiner dans quelle mesure les symptômes dépressifs à l'entrée de la RP permettent de 
prédire 1) la présence aux séances de RP, 2) le respect de l'intensité (conformité) des 
exercices d’endurance prescrits pendant la RP, et 3) le niveau d’exercice physique 
maintenu 9 mois après la RP. Un deuxième objectif consistait à explorer d'autres variables 
susceptibles d'être associées à ces paramètres. Trente-six patients (64 % de femmes) 
atteints de la MPOC stable, modérée à sévère, ont été inscrits à un programme de RP de 
12 semaines comportant 36 séances d’exercice physique supervisé. À l’entrée du RP les 
patients ont rempli l’Inventaire de Dépression de Beck (BDI-II, le prédicteur principal) et 
 iv 
le formulaire C de l’Échelle du locus de contrôle sur la santé (LCS), et ont subi des tests 
de fonction pulmonaire et une épreuve d’effort progressif à vélo (pour déterminer 
l'intensité de l'exercice pour la RP). Ensuite, ils ont été répartis de façon aléatoire dans 
trois groupes à intensité d’exercice différente. La fréquentation de la RP était définie 
comme le pourcentage de séances suivies; la conformité, comme la durée d’entraînement 
pratiquée à la fréquence cardiaque cible; et le maintien de l'exercice physique régulier 
comme le niveau d’exercice fait au cours d’une semaine 9 mois après la RP (enregistré 
dans un journal d’activité physique et calculé en équivalents métaboliques de l’effort 
[MET] minutes ). La médiane (écart interquartile ou IQR) du score au BDI-II était de 8,5 
points (6-13), la médiane (IQR) du taux de la fréquentation aux séances était de 83% (67-
94), la médiane du taux de compliance à l’intensité d'exercice était de 94% (71-99), et la 
médiane du nombre de minutes MET après la RP était de 706 (445-1146). Les analyses 
de régression linéaire ne montrent pas de relation entre les symptômes dépressifs pré-RP 
et  la fréquentation des séances de la RP (ß = 0,12; p = 0,478). Par-contre, ils étaient 
associés à la conformité à l'intensité de l’exercice physique pendant la RP (ß = -0,40; p = 
0,047), et à la poursuite de la pratique d’un exercice physique régulier après la RP (ß = -
0,50; p = 0,004). Les analyses étaient ajustées pour des covariables prédéfinies. Les 
analyses exploratoires ont révélé que certaines variables supplémentaires (y compris LCS) 
étaient associées aux issues mesurées. Les résultats de cette étude montrent que même les 
niveaux de dépression sous-cliniques pourraient jouer un rôle important dans la 
compliance aux programme de réentraînement, et au maintien d’un style de vie actif après 
la période de réadaptation. Cela a des implications pour améliorer le dépistage des 
 v 
« mauvais » résultats dans la RP et pour l'élaboration d'interventions ciblées pour 
améliorer les bénéfices pour la santé découlant de la réadaptation pour la MPOC.  
 
Mots clés : Maladie pulmonaire obstructive chronique, MPOC, réadaptation pulmonaire,  
dépression, locus de contrôle sur la santé, prédicteurs, conformité, maintien. 
  
Abstract 
Chronic obstructive pulmonary disease (COPD) is an irreversible, progressive, and highly 
prevalent respiratory illness that poses a great burden on the healthcare system, patients, 
and their families. Pulmonary rehabilitation (PR) is effective in reducing dyspnea and 
health care resource utilization, and increasing exercise capacity and quality of life. 
Exercise training is the cornerstone of PR but is only beneficial if patients 1) attend 
sessions, 2) comply with the prescribed exercise regimen, and 3) maintain regular exercise 
after supervised PR ends. Comorbid depression is disproportionately high in COPD and 
has been found to predict poor attendance at PR and low levels of exercise maintained 
afterwards. To our knowledge, no study has investigated predictors of exercise 
compliance during PR, and only a few studies have examined predictors of exercise 
maintenance post PR. The primary objective of this study was to examine how much 
baseline depressive symptomatology can predict 1) PR attendance, 2) PR exercise 
compliance, and 3) levels of exercise maintained at 9-months post PR. A secondary, 
exploratory objective was to identify additional variables that might also have significant 
associations with these outcomes. Thirty-six patients (64% female) with stable COPD 
were enrolled in a 12-week 36-session supervised exercise intervention in the context of 
a PR program. Patients underwent evaluations at entry to PR which included the Beck 
Depression Inventory (BDI-II, the main predictor), the Multidimensional Health Locus of 
Control (HLC) Scale Form-C, pulmonary function tests, and an incremental cycling test 
(to determine the exercise intensity prescription).  Patients were randomized to one of 
three groups of varying exercise intensity. Attendance was defined as the percent of total 
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sessions attended, compliance as the percent of endurance training time exercising at a 
prescribed target heart rate, and post-PR exercise as the total exercise performed over a 7-
day period recorded in a physical activity diary and calculated as metabolic equivalent of 
task (MET) minutes. Median (IQR) baseline BDI-II was 8.5 (6-13), median (IQR) percent 
attendance was 83 (67-94), median (IQR) percent exercise compliance was 94 (71-99), 
and median (IQR) exercise MET-minutes post PR was 706 (445-1146). In multiple 
regression analyses, baseline depressive symptomatology did not emerge as a significant 
independent predictor of PR attendance (ß = .12, p = .478), but was a significant predictor 
of PR exercise compliance (ß = -.40, p = .047), and of exercise maintained post PR (ß = -
.50, p = .004), with adjustment for a-priori defined covariates. Secondary exploratory 
analyses revealed that certain additional variables (including HLC) had associations with 
particular outcomes. The findings suggest that even subclinical levels of depression can 
predict PR exercise compliance and post-PR exercise levels. This has implications for 
improving screening for, and understanding of, poor outcomes in PR and for developing 
targeted interventions to optimize the health benefits that can be derived during and after 
PR for COPD.  
 
Key words: Adherence, chronic obstructive pulmonary disease, COPD, depression, 
pulmonary rehabilitation, health locus of control, predictors.  
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Introduction
  
Decades ago, chronic illnesses surpassed acute medical conditions, such as 
infectious diseases and injuries, as the major cause of death and disability in developed 
countries, due mainly to improved living conditions and nutrition and to medical advances 
such as vaccines and antibiotics (Cohen, 2000). Unfortunately, rates of chronic illness 
now continue to rise largely as a result of increased longevity and widespread lifestyle and 
behavioral factors (e.g., smoking, unhealthy diet, and physical inactivity) (OECD, 2011; 
Ward, Schiller, & Goodman, 2014). It is estimated that 3 out of every 5 Canadians over 
20 years old now have at least one chronic medical condition and that these account for 
67 % of all direct health care costs (Elmslie, 2012). The effective management of chronic 
illness is so different from that of acute illness/injury that it has prompted a paradigm shift 
in health care for both providers and patients: The focus has shifted from curing illness to 
its management (Holman & Lorig, 2004). Patients are no longer passive recipients of care 
provided by experts; instead they work in partnership with healthcare professionals and 
play an active role in their health care by acquiring knowledge and adopting behaviors 
that support health and diminish symptoms, and by abandoning other behaviors that are 
detrimental. As a result, the importance and application of psychology and behavioral 
science in physical health is evolving to help meet the challenges of adopting and 
maintaining behaviors that enhance health in chronic illness. 
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Chronic obstructive pulmonary disease (COPD) is an irreversible and progressive 
illness characterized by expiratory airflow obstruction, increasing shortness of breath, and 
respiratory tract infections (O'Donnell et al., 2007), that limits activity levels and reduces 
quality of life. It is a leading cause of hospitalization and mortality, and its prevalence is 
increasing (Canadian Institute for Health Information, 2008; World Health Organization, 
2008).  As such, it poses a tremendous financial and humanistic burden on society, the 
healthcare system, patients, and their families. 
 
Effective management of COPD involves a multi-faceted approach, which includes 
early diagnosis, pharmacotherapy, and changes in lifestyle and behavior (e.g., quitting 
smoking) on the part of the patient, that support health (Celli et al., 2004). However, 
pulmonary rehabilitation (PR) is firmly established as the most effective therapeutic 
strategy for decreasing dyspnea, increasing functional capacity, improving quality of life, 
and reducing healthcare utilization (including hospitalizations) when symptoms persist 
despite pharmacotherapy (McCarthy et al., 2015). PR is comprised of patient education 
and the acquisition of self-management skills, but it is the exercise training component 
that is considered the cornerstone from which most of the above-mentioned benefits are 
derived (Global Initiative for Chronic Obstructive Lung Disease [GOLD], 2016). 
Although PR has been shown to be highly beneficial, it can be challenging for patients to 
engage in due to their COPD symptoms, such as dyspnea and fatigue, as well as the high 
prevalence of comorbidities (Chatila, Thomashow, Minai, Criner, & Make, 2008). 
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In this study, exercise “adherence” during PR is comprised of two distinct yet 
essential components: attendance at exercise sessions and compliance with prescribed 
aerobic exercise intensity. Attendance is defined as being present at PR exercise sessions. 
Exercise compliance is defined as performing physical exercise at a level of intensity 
sufficient to achieve and sustain a target heart rate that was prescribed for PR for a specific 
duration. Our measure of PR exercise adherence is therefore the product of PR attendance 
and PR exercise compliance (i.e., percent of total PR sessions attended multiplied by the 
percent of total exercise time during which exercise was performed at the prescribed target 
heart rate). Continuing regular exercise after termination of supervised PR is referred to 
as maintenance in this study and is quantified as the total volume of exercise performed 
over 7 consecutive days at follow-up (9 months post PR). 
  
Levels of uptake and attendance1 at exercise-based PR, as well as amount of exercise 
maintained post PR, have been found to be fairly poor (Cindy Ng, Mackney, Jenkins, & 
Hill, 2012; Hogg et al., 2012; Soicher et al., 2012). This has prompted investigation into 
their determinants. A wide variety of environmental, demographic, medical, personal, and 
psychological factors have been identified, but findings are often inconsistent from one 
study to the next (Cassidy, Turnbull, Gardani, & Kirkwood, 2014; Keating, Lee, & 
Holland, 2011).  
                                                 
1 In previous studies, the term “adherence” has been used (perhaps misused) by authors 
to denote what is in fact attendance only (expressed as a percentage of the total number 
of PR sessions at which participants are present).  
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However, depression, both clinical and subclinical,2 has emerged repeatedly as a 
robust predictor of PR attendance and post-PR exercise maintenance (Roshanaei-
Moghaddam, Katon, & Russo, 2009; Thorpe, Johnston, & Kumar, 2012). This is 
particularly relevant because clinically significant symptoms of depression have been 
found to be disproportionately high in COPD (as much as 40 % prevalence) (Yohannes, 
Willgoss, Baldwin, & Connolly, 2010) compared to the general population of older 
community-dwelling adults (15 % prevalence) (Blazer, 2003). Therefore, understanding 
depression as a potential predictor of attendance and exercise compliance during PR, and 
of exercise levels maintained post PR may be particularly important for optimizing the 
treatment and management of COPD. 
 
A weakness of previous studies on predictors of so called exercise “adherence” 
during PR is that, to our knowledge, they have only measured attendance at PR sessions 
but not also compliance with the exercise prescribed for PR. This leaves an important gap 
in the literature. Reporting on attendance at PR exercise sessions is an inadequate measure 
of adherence, as it does not provide information on the extent to which participants 
actually meet the exercise targets determined to be associated with health and functional 
                                                 
2 Clinical depression is defined as meeting the criteria set forth in the DSM-IV-TR 
(American Psychiatric Association, 2000) for a diagnosis of major depressive disorder, 
which is the presence of at least five of the following nine symptoms that must include 
at least one of the first two: depressed mood, loss of interest or pleasure in most 
activities, significant change in appetite or weight, hypersomnnia or insomnia, 
psychomotor retardation or agitation, loss of energy, feeling worthless or guilty, 
difficulty concentrating, and recurrent thoughts of death or suicide. Subclinical (or 
clinically significant symptoms of) depression impacts functioning significantly and 
causes suffering, but is less severe and does not meet the criteria for clinical depression.  
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benefits. PR “adherence” studies must assess both attendance and exercise compliance 
during PR, and ideally post-PR exercise, as baseline levels of depressive symptoms may 
differentially predict each of these outcomes. This study seeks to help fill this gap in the 
PR literature for COPD. 
 
Given the importance of patients’ active involvement in managing their COPD, 
health locus of control (HLC) is a variable of interest included in this study’s secondary 
analyses. Health locus of control is a construct from social cognitive theory (Bandura, 
1986) pertaining to people’s beliefs about where the responsibility and control for their 
health resides. There are two distinct HLC orientations: internal is the belief that control 
and responsibility resides within oneself, and external is the belief that factors outside 
oneself (chance, doctors, or other people) are responsible (Wallston, Stein, & Smith, 1994; 
Wallston, Wallston, & DeVellis, 1978). Although HLC has been shown to be relevant for 
a variety of health-related and safety behaviors across a wide range of illnesses and 
situations that pose risks to one’s health/safety, it has not to our knowledge been studied 
previously in the context of PR or COPD. 
 
In light of the above, the primary objective of this thesis is to investigate the extent 
to which baseline depressive symptomatology can predict PR attendance, PR exercise 
compliance (collectively defined as “adherence”), and levels of exercise maintained 9 
months after PR. A secondary exploratory objective is to identify additional potential 
predictors (such as health locus of control) of each outcome. The results may contribute 
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to a better understanding of what factors are related to optimally benefitting from an 
exercise-based PR program for COPD and to developing interventions and resources that 
effectively target them. 
 
This thesis is divided into five main sections. The first section describes COPD and 
exercise-based PR as a key component of its management.  Suboptimal levels of physical 
activity/exercise in the general adult population and in the context of PR for COPD 
specifically are presented and factors found to be linked to these are discussed. The 
prevalence and importance of depressive symptomatology is highlighted. The first section 
ends with a presentation of this study’s objectives and research hypothesis. Next, the 
methods section describes the design of this study, its participants, procedure, variables of 
interest and their measures, and the statistical analyses employed. The results from our 
statistical analyses are presented in the third section. The fourth section is a discussion of 
the findings and how they pertain to the objectives, hypotheses, and previous findings 
reported in the literature. This study’s strengths and limitations are described and several 
suggestions for future research are proposed. In the fifth and final section, the conclusions 
and clinical implications are presented.
  
Theoretical Context
  
COPD: Definition, Causes, Prevalence, and Burden 
COPD refers to a combination of respiratory disorders resulting in progressive 
irreversible airflow obstruction, lung hyperinflation, and increasingly frequent respiratory 
tract infections O'Donnell et al. (2007). Inflammatory processes cause narrowing of small 
airways and destruction of alveoli (air sacs in the lining of the lungs) resulting in loss of 
lung tissue elasticity and chronic expiratory airflow limitation (Celli et al., 2004). 
Prominent symptoms of COPD include progressive shortness of breath (dyspnea), 
especially upon physical exertion, coughing, and excessive sputum production. Tobacco 
smoking is the principle cause, accounting for 80-90 % of cases in North America (Office 
of the Surgeon General, 2004; Public Health Agency of Canada, 2007). Other risk factors 
include air pollution, occupational exposure to dust and fumes, respiratory infections, and 
a genetic deficiency of alpha1-antitrypsin (Global Initiative for Chronic Obstructive Lung 
Disease [GOLD], 2016).  
 
COPD is currently the world’s (including Canada) fourth leading cause of mortality 
(Statistics Canada, 2008; World Health Organization, 2008) and as the population ages, 
morbidity and mortality rates are expected to continue to rise such that by 2020, COPD is 
expected to become the third leading cause of death (Mittmann et al., 2008; Murray & 
Lopez, 1997; Public Health Agency of Canada, 2007). Currently a leading cause of 
hospital admission in Canada, COPD was recently reported to have the highest rate of 
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readmission of all major chronic illnesses: following a first hospital admission, the 12-
month readmission rate was 18 %, while 14 % of patients were admitted three or more 
times (Canadian Institute for Health Information, 2008). As such, COPD represents a 
substantial burden on the healthcare system. In a recent systematic review Dang-Tan, 
Ismaila, Zhang, Zarotsky, and Bernauer (2015) estimated that the total annual cost of 
COPD in Canada, including costs of healthcare and work/productivity losses, was 5.3 to 
9 billion 2012 Canadian dollars. This was based on the estimated prevalence of 1.4 million 
Canadians with COPD, which most likely underestimates the real prevalence due to under 
diagnosis  (J. Evans, Chen, Camp, Bowie, & McRae, 2014).   
 
Identifying ways to improve treatment for, management of, and quality of life in 
COPD is vital to reducing its substantial economic and humanistic burden on society, 
patients, and their families. 
 
Pulmonary Rehabilitation: The Standard of Care for COPD 
Effective management of COPD requires a multifaceted approach comprised of 
medical diagnosis and monitoring, pharmacologic treatment, and lifestyle changes in 
which patients play an active role in adopting and maintaining health behaviors. Now a 
consensus among the Canadian and American Thoracic Societies, the European 
Respiratory Society, and the World Health Organization, pulmonary rehabilitation (PR) 
is considered a cornerstone in the best management of stable COPD when symptoms 
persist despite pharmacotherapy (Marciniuk et al., 2010) and is “the most effective 
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therapeutic strategy for improving dyspnea, exercise endurance and quality of life” 
(O'Donnell et al., 2007, p. 19B) as well as reducing health care utilization. There is also 
convincing evidence that undergoing PR soon after an acute exacerbation of COPD 
improves physical endurance, and reduces hospital readmissions and mortality compared 
to usual care (Puhan et al., 2011). PR is a grade-A evidence-based treatment whose main 
goals are to reduce symptoms, increase tolerance for physical activity and engagement in 
activities of daily living, and enhance quality of life (Nici et al., 2006; Ries et al., 2007). 
The American Thoracic Society and European Respiratory Society (Spruit et al., 2013) 
have defined PR as: 
A comprehensive intervention based on a thorough patient assessment followed 
by patient-tailored therapies, which include, but are not limited to, exercise 
training, education, and behavior change, designed to improve the physical and 
psychological condition of people with chronic respiratory disease and to promote 
the long-term adherence of health-enhancing behaviors. (p. e16) 
 
 
The above-mentioned benefits of PR are strongly established (McCarthy et al., 
2015) and are attributed mainly to the physical exercise component (GOLD, 2016), the 
foundation of which is endurance (aerobic) training, but with additional benefit derived 
from resistance training (Gosselink et al., 2011; Marciniuk et al., 2010). This is because 
exercise helps reverse the systemic (extra-pulmonary) effects of COPD – mainly skeletal 
muscle dysfunction/wasting – which results in loss of strength and endurance (Troosters, 
Gosselink, Janssens, & Decramer, 2010). Therefore, the Canadian Thoracic Society 
strongly recommends that all patients with moderate to very severe COPD have access to 
and undergo PR (Marciniuk et al., 2010), while R. A. Evans, Singh, Collier, Williams, 
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and Morgan (2009) found that all people with COPD can benefit regardless of disease 
severity. 
 
Endurance Training in PR: How Often, How Intense, and for How Long? 
PR exercise guidelines recommend that participants engage in continuous 
endurance training (usually walking, cycling, or treadmill) for at least 20 to 30 minutes 
three to five times per week at a high intensity; i.e., 6080 % of maximal work rate 
(Garvey, 2016). This is the amount required to improve cardiac function and produce the 
anabolic stimulus that can reverse skeletal muscle dysfunction by improving the oxidative 
capacity of muscle (Vogiatzis et al., 2007), which helps reduce dyspnea and fatigue, and 
increase functional capacity. However, a large proportion of people with COPD are unable 
to achieve and sustain high intensity training because of severe symptoms and limited 
functional capacity (Maltais et al., 1997). Therefore, alternative approaches to exercise, 
such as interval training (IT) and training at the ventilatory threshold have been 
recommended and shown to be effective (Beauchamp et al., 2010; Rochester, 2003). 
Exercising at the ventilatory threshold is a more moderate level of training that is better 
tolerated, especially by people with more severe COPD, than exercising at higher 
intensities. The ventilatory threshold is the point above which the rate of respiration starts 
to increase more rapidly than the level of oxygen consumption. When people exercise 
above their ventilatory threshold, they usually experience the sensation of not being able 
to breathe fast or deep enough to satisfy the body’s demand for oxygen. IT (interval 
training) is comprised of segments of high-intensity exercise that alternate with periods of 
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low intensity or rest, and is also better tolerated than continuous training by people with 
more advanced COPD. IT has been shown to be as effective as continuous training for 
improving exercise capacity and health-related quality of life when the total volume of 
work performed is equal to that recommended for continuous training (Beauchamp et al., 
2010; Vogiatzis, Nanas, & Roussos, 2002). The recommended PR program duration is  
8 weeks, with some evidence suggesting that longer programs may result in higher levels 
of physical activity being maintained after PR program termination (Garvey et al., 2016). 
 
The Widespread Problem of Inadequate Physical Activity/Exercise 
The terms physical activity and exercise are often used interchangeably in the 
literature but actually represent distinct behaviors and objectives. For the present paper, 
physical activity is defined as “any bodily movement produced by skeletal muscles that 
results in energy expenditure. . . . Physical activity in daily life can be categorized into 
occupational, sports, conditioning, household, or other activities” (Casperson, Powell, & 
Christenson, 1985, p. 126). In contrast, exercise is a “subset of physical activity that is 
planned, structured, and repetitive and has as a final or an intermediate objective the 
improvement or maintenance of physical fitness” (Casperson et al., 1985, p. 126). 
 
Achieving and maintaining levels of physical activity and exercise sufficient for the 
maintenance of good health is a formidable challenge across all age groups, but especially 
for older adults with chronic illness. A recent survey by Colley et al. (2011) found that 
only 15.4 % of adults in the general Canadian population were achieving and maintaining 
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the weekly amount of physical activity recommended by the Canadian Society for 
Exercise Physiology (2012) and World Health Organization (2010), which is 150-minutes 
of moderate-intensity aerobic physical activity per week in addition to the normal 
activities of daily living. The percentage of older adults with COPD meeting this 
recommendation is likely much lower. For example, a study comparing everyday physical 
activity levels in patients with COPD to those of healthy age-matched controls found that 
the patients engaged in 41 % less time walking, 35 % less time standing, and 25 % lower 
movement intensity when they did walk (Pitta et al., 2005). It follows that the low levels 
of physical activity, and factors underlying this, impact levels of participation in exercise-
based PR. 
 
Rates of PR “Uptake” and Attendance, and Maintenance of Physical  
Activity Post-PR 
Several studies show that many participants do not fully benefit from PR due to 
absenteeism or dropout during the program, and an even greater proportion do not 
maintain adequate levels of physical activity afterwards. In a study of seven PR programs, 
only 73 % of the eligible 1114 COPD patients referred for PR attended assessments, 59 
% then started PR, and only 40 % completed the program (Hogg et al., 2012). Garrod, 
Marshall, Barley, and Jones (2006) reported that among the 69 % of patients who 
completed a 7-week 14-session PR program, they attended an average of only 71 % of all 
sessions. In the recent Cochrane review of RCTs of PR by McCarthy et al. (2015), 23 of 
the 58 studies reporting on dropout had rates of > 20 % (range 21-48 %). In one of the few 
studies measuring adherence to a PR exercise program for patients who had recently 
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experienced a COPD exacerbation, S. E. Jones et al. (2014) reported that only 48 % of the 
patients who had attended initial assessment completed PR. In a longitudinal study, which 
measured maintenance of exercise over a 9-month period following a PR program, 
Soicher et al. (2012) found that at 1 month post PR, only 36 % of participants had 
maintained the minimum weekly level of exercise recommended to them, while at 9 
months, the proportion had dropped to just 26 %. A recent systematic review and meta-
analysis demonstrated that increases in exercise capacity acquired during PR translated 
into only small increases of physical activity in daily life. However, these measures were 
always taken during the last week of – or within 14 days after – PR  termination (Cindy 
Ng et al., 2012). Therefore, this meta-analysis did not demonstrate any lasting changes in 
physical activity in daily life beyond the time of the PR programs. In an official statement 
from the European Respiratory Society on physical activity in COPD, Watz et al. (2014)  
concluded that the 10 studies they indentified that evaluated the impact of PR on physical 
activity in COPD produced inconsistent results (six showing negative results). Of those 
showing increases in PA, the increases were all assessed and found immediately at the 
end of PR, thus providing no evidence that PR is linked to increased physical activity (or 
exercise) post PR.  This lack of sustained exercise is likely a main reason why the gains 
acquired during PR are frequently lost within 12 months following program termination 
(Griffiths et al., 2000; Luk, Khan, & Irving, 2015; Moullec, Ninot, Varray, & Prefaut, 
2007; Ries, Kaplan, Limberg, & Prewitt, 1995; Ries, Kaplan, Myers, & Prewitt, 2003).  
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Health Risks Associated with Physical Inactivity 
For the general population, physical inactivity is a modifiable risk factor for 
coronary heart disease, stroke, certain cancers, type 2 diabetes, osteoporosis, cognitive 
decline and dementia, anxiety, depression, poor quality of life, hospital admission, and 
all-cause mortality (Garber et al., 2011). In addition to these, the potential consequences 
of physical inactivity specific to COPD include an increase in acute exacerbations, 
dyspnea and mortality, and a decrease in exercise capacity and quality of life according to 
a recent systematic review by Gimeno-Santos et al. (2014). For people with COPD, the 
consequences of inactivity also frequently manifest in a particular interplay of symptoms 
and behaviors, which is commonly referred to as the “vicious cycle” or “downward spiral” 
of COPD (Garvey, 2016; Nici et al., 2006): Dyspnea can cause anxiety and fatigue that 
may lead to avoidance of physical activity, which results in general deconditioning that 
can increase dyspnea, foster further inactivity and isolation, and result in poor quality of 
life (see Figure 1). PR, with its emphasis on exercise, is an intervention that can prevent, 
delay, and even reverse this downward trajectory by slowing the decline in physical 
activity and functional capacity. 
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Figure 1. The downward spiral of COPD. This is a common pattern of interplay between 
disease symptoms and people’s responses that can diminish quality of life. Adapted from 
La Clinique du Souffle la Solane, Osséja, France. 
 
The disparity between the many benefits of being active and the low levels of 
engagement in regular physical activity and exercise has prompted investigation into their 
determinants in both healthy and clinical populations with the goal of reducing this 
evidence-practice gap. 
 
Determinants of Physical Activity and Exercise 
Physical activity (including exercise) is a complex behavior whose intensity, 
duration, frequency, and maintenance are determined not solely by health status and 
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functional capacity, but by a variety of personal, social, and environmental factors as well. 
For example, smoking status, exercise history, body mass index, sociodemographic 
variables (e.g., age, sex, education, marital and economic status), social/family support 
for exercise, proximity of exercise facilities, type of exercise activity, and the weather 
have all been linked to levels and frequency of physical activity and exercise  (Courneya 
et al., 2008; Dishman & Sallis, 1994; Martin & Sinden, 2001; Trost, Owen, Bauman, 
Sallis, & Brown, 2002; White, Ransdell, Vener, & Flohr, 2005). Furthermore, several 
psychological and social-cognitive factors, such a mood state, self-efficacy, and locus of 
control for health, have also been implicated (Friis, Nomura, Ma, & Swan, 2003; Gimeno-
Santos et al., 2014). 
 
Of these, depression in particular (both subclinical and clinical levels) has 
repeatedly been linked to lower levels of physical activity and exercise in both the general 
population and across a range of chronic illnesses. Roshanaei-Moghaddam et al. (2009), 
for example, conducted a review of 11 studies on the longitudinal relationship between 
baseline depression and ensuing changes in physical activity levels. Eight studies reported 
that baseline depression was a significant risk factor for a decline in levels of physical 
activity, but also for poor adherence to specific physical exercise regimens following a 
recent coronary event. A ninth study found that emerging (as opposed to baseline) 
depression was associated with a corresponding shift from being physically active to 
becoming sedentary. DiMatteo, Lepper, and Croghan (2000)  conducted a meta-analysis 
comprised of 12 studies that investigated associations between depression and adherence 
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to medical regimens (including exercise) in a variety of chronic conditions such as renal 
disease, arthritis, angina, and cancer. They found that depression was consistently 
associated with poorer adherence, with the odds of nonadherence being 3 times higher 
among depressed versus non-depressed patients. In a 36-session exercise-based cardiac 
rehabilitation program, Glazer, Emery, Frid, and Banyasz (2002) found that baseline 
depression symptoms were a significant predictor of lower attendance and higher rates of 
dropping out altogether. In a systematic review of 20 studies on adherence to 
physiotherapy treatment (including prescribed exercise) for musculoskeletal problems, 
Jack, McLean, Moffett, and Gardiner (2010) found “strong” evidence that baseline 
depression was a barrier to adherence.  
 
What is known about the predictors of attendance and exercise compliance during 
PR for COPD (i.e., attending sessions and complying with prescribed exercise) and of 
exercise maintenance after PR? Is depression a significant barrier to participating and 
benefitting from PR? Answering these questions is a crucial part of gaining a better 
understanding of how to improve PR outcomes. 
 
Requirements for Obtaining Optimal Benefits from PR 
Attaining optimal health benefits from PR is dependent upon participants meeting 
three fundamental requirements: 1) Attending PR sessions, 2) complying with the 
prescribed intensity and duration of aerobic exercise, and 3) maintaining regular physical 
exercise after supervised PR ends. Participants who do not adequately meet these 
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requirements will not obtain much benefit during PR, or the gains acquired during the 
program will erode thereafter. Obviously, individuals have to attend PR exercise sessions 
to avail themselves of what the program offers. When present, participants also have to 
engage in aerobic exercise with at least some degree of compliance to the recommended 
intensity and duration to acquire health benefits. Finally, and perhaps most importantly, if 
regular endurance exercise is not maintained after PR, exercise-related improvements will 
diminish over time. The findings from studies that examined predictors of PR attendance, 
exercise compliance, and exercise maintenance are presented below.  
 
Predictors of Attendance at Exercise-Based PR 
In the National Emphysema Treatment Trial (Fan, Giardino, Blough, Kaplan, & 
Ramsey, 2008) multivariate regression analysis revealed that lower socioeconomic status 
(income) and lung function, greater anxiety, depressive symptoms, and distance to the PR 
center were all independent predictors of significantly lower PR attendance rates among 
1218 COPD patients with severe airflow limitation (forced expiratory volume in the first 
second [FEV1] ≤ 45 % predicted). Of note is that even relatively low levels of baseline 
depressive symptoms were associated with significantly lower odds of completing PR.  
 
In a systematic review of 11 studies (total N = 2039) investigating PR uptake and 
completion, Keating et al. (2011) reported that travel, transport, baseline smoking and 
depression consistently emerged as predictors of failure to complete exercise based PR 
for COPD. Cassidy et al. (2014) conducted a study involving 651 respiratory patients (87 
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% with COPD) on the physiological and psychological predictors of completing a 6-week 
(12 sessions) PR program. In multiple logistic regression analysis, the strongest predictor 
of PR completion was currently not smoking, while the second strongest was a component 
they derived from factor analysis which they labelled “psychological well-being.” This 
was made up of five factors: The Chronic Respiratory Disease Questionnaire’s fatigue, 
emotion, and mastery domains; and levels of anxiety and depression from the Hospital 
Anxiety and Depression Scale. Here again, depression was linked to PR attendance.  
 
A multi-center study conducted in the Netherlands by Fischer et al. (2009), 
involving 271 COPD patients, found using hierarchical logistic regression analysis that 
lower fat free mass index and perception of lower treatment effectiveness were 
independent predictors of significantly lower PR attendance. They did not report on 
depression in their study. 
 
In a large retrospective study (N = 711) recently done in the U.K., Hayton et al. 
(2013)  identified predictors of attendance (defined as attending at least one PR session) 
and “adherence” 3 (present at > 63 % of eight weekly exercise training sessions). 
Independent predictors of non-attendance, based on a multivariate analysis, were: use of 
long-term oxygen therapy and living alone. Independent predictors of poor “adherence” 
(present at < 63 % of PR sessions) were current smoking, shorter incremental shuttle walk 
test distance, and previous hospital admission. Depression was not included in predictive 
                                                 
3 Adherence” was the term used by the authors, but it actually denotes attendance. 
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analyses because of missing data, however, patients who dropped out of PR because of 
acute exacerbations of COPD had Hospital Anxiety and Depression Scale depression 
scores that were on average 56 % higher than those who completed PR.  
 
In a prospective observational study, Hogg et al. (2012) identified predictors of PR 
completion rates in a large sample across seven centers (two in hospital and five in the 
community). Four centers had rolling recruitment (accepting new patients every week) 
and provided PR sessions twice weekly for 8 weeks, while three centers had cohort 
recruitment (all patients starting and finishing together) with one PR session per week for 
8 weeks. Completion was defined as attending 50 % of sessions (8 out of 16) for the rolling 
recruitment groups and attending 75 % (6 out of 8) for the cohort recruitment groups. Of 
656 patients who started PR, 441 (67 %) completed. Using multivariate logistic 
regression, independent predictors of lower completion rates were the Hospital Anxiety 
and Depression Scale depression score of  11 (the caseness threshold), Medical Research 
Council dyspnea scale score of 4 or 5 (high severity of COPD), greater Index of Multiple 
Deprivation score (socio-economic deprivation based on geographic area), and referral by 
a general practitioner (instead of a medical specialist). Depression had a significant effect 
with an adjusted odds ratio of 0.56 (95 % CI 0.37–0.85) for PR completion. It should be 
noted however that these variables combined explained only 10 % of the variance in the 
PR completion rate.  
 
Thorpe et al. (2012) conducted a systematic review to identify both barriers and 
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enablers of participation in physical activity and exercise-based pulmonary rehabilitation 
programs. From 11 studies (three quantitative and eight qualitative) that met their 
inclusion criteria for study quality, six barriers and seven enablers were identified. The 
barriers were: “Personal issues” (fear and uncomfortable feelings regarding exercise, 
presence of depression), health status (degree of dyspnea, frequency of exacerbations), 
“external factors” (weather, financial situation, transport, unforeseen events), “lack of 
support” (living alone, social isolation), “program-related issues” (too long, influence of 
referral source, lack of perceived benefit), and current smoking. “Personal issues,” which 
included depression, was the only barrier to emerge in all 11 studies included in this 
review. The enablers of participation that they identified were: “personal drivers” 
(personal values and motivators that maintain exercise), “personal attributes and perceived 
benefits” (persistence, positive attitude towards exercise, belief in its benefits), “social 
support” (giving and receiving emotional support, interacting with and learning from 
others), “control of condition” (taking an active role engaging in health behaviors that 
impact health and autonomous functioning), “program-centric enablers” and “professional 
support” (referral by a trusted medical practitioner, guidance and monitoring by qualified 
staff), and “goal setting” (improve functional capacity and autonomy, reduce symptoms). 
 
Taken together, these studies show that attendance at PR is associated with a wide 
range of factors, including different levels of depression (subclinical or clinical). 
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Predictors of Compliance with Prescribed Exercise During PR 
To our knowledge, no studies have been conducted on the predictors of compliance 
with exercise (specifically, the prescribed intensity and duration) during PR, which 
represents an important gap in the literature. “Adherence” studies to date have only 
measured and reported on attendance at PR, however, being present at PR sessions does 
not indicate whether or not participants are exercising to target. One cannot report on the 
predictors of exercise adherence in PR without addressing both attendance at exercise 
sessions and compliance with the recommended exercise duration and intensity.  
 
Predictors of Maintenance of Physical Activity and Exercise after PR 
Only a few studies have examined post-PR maintenance of physical 
activity/exercise and their predictors in COPD patients. Usually, activity levels decline 
over time and the improvements in exercise tolerance acquired during PR erode such that 
by 12-months post PR, these gains are lost. Even when patients participate in a post-PR 
maintenance program, although they may preserve some gains initially, by the end of the 
maintenance intervention most patients’ exercise capacity is usually no different from 
those who received only standard care (Busby, Reese, & Simon, 2014).  
 
In a recent systematic review, Beauchamp, Evans, Janaudis-Ferreira, Goldstein, and 
Brooks (2013) compared the effect of supervised exercise maintenance programs versus 
usual care on exercise capacity at 6 and 12 months after PR. The outcomes of seven RCTs 
involving 619 individuals with moderate to severe COPD showed an average 60 % rate 
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of attendance to the exercise maintenance program at 1-year post PR. At 6-months post 
PR, the functional exercise capacity of participants in the maintenance groups was 
significantly greater than that of usual care. However, this effect was not sustained at 12 
months when the exercise capacity of the maintenance and control groups were 
indistinguishable. Unfortunately, this study did not report on participant characteristics 
that predicted attendance or dropout. 
 
Heerema-Poelman, Stuive, and Wempe (2013) examined predictors of adherence to 
an exercise maintenance program of 1-year duration following initial PR. Sixty patients 
with COPD participated in a maintenance program offered in primary care settings and 
supervised by physiotherapists trained in PR for COPD. “Adherence” was defined as 
attending maintenance sessions for the full year, however the authors do not state the 
number of sessions per week nor if all the exercise sessions took place at a rehabilitation 
center or partly in the home setting. At 12 months, 63 % of participants were still following 
the maintenance program. Independent predictors of “nonadherence” (defined as not 
attending up to 1 year) that emerged from multiple logistic regression analyses were: more 
severe COPD (indicated by lower forced expiratory volume in the first second [FEV1]), 
more depressive symptoms (measured by the Hospital Anxiety and Depression Scale), 
and shorter duration of the initial PR program. 
 
In a unique longitudinal study investigating the changes in levels of endurance 
exercise following a 12-week PR program for COPD, Soicher et al. (2012) identified 
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patterns of endurance exercise levels (based on a self-reported 1-week exercise log) and 
characterized individuals who did not maintain adequate exercise for health after PR. 
Endurance exercise levels were measured using a semi-structured telephone interview at 
4, 6, 8, and 12 months after the start of a 12-week PR program. Overall, levels of exercise 
declined following termination of the PR program. Three trajectory classes based on 
endurance exercise patterns were identified: “low” (mean exercise time of 1.0 hour per 
week at 1 month post-PR and 0.7 hours per week at 9 months post-PR), “high” (mean of 
2.7 hours per week at 1 month post-PR and 3.2 hours at 9 months), and “high/decline” 
(mean of 3.0 hours per week at 1 month falling to 0.8 hours per week at 9 months post-
PR). Stepwise multivariate discriminant analysis yielded three variables that 
discriminated significantly between the three trajectory classes: exercise history, baseline 
six-minute walking distance, and number of current barriers to exercising (e.g., too tiring, 
too costly, too far away, family commitments, working). Although depression was 
measured at baseline using the Geriatric Depression Scale, and 25 % of the sample was 
found to have “possible” or “probable” depression (i.e., a score of  6), the authors did 
not report on whether depression levels helped characterize participants in the three 
exercise trajectories. 
 
The above findings demonstrate that maintenance of exercise post-rehabilitation is 
poor and is associated with a range of factors, among which depression appears to play a 
significant role. 
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Prevalence of Depression in COPD 
Not only has depression (both subclinical symptoms and clinical disorders) emerged 
as an important determinant of physical activity/exercise levels, PR attendance and 
outcomes, it has been established that comorbid depression is highly prevalent in patients 
with COPD compared to the general population. Several reviews have estimated the 
prevalence of clinically relevant depression in COPD to be as high as 40 % (K. M. 
Hynninen, Breitve, Wiborg, Pallesen, & Nordhus, 2005; Mikkelsen, Middelboe, Pisinger, 
& Stage, 2004; Yohannes, 2005; Yohannes et al., 2010) compared to approximately 11 % 
in the general population of North American adults ≥ age 65 (Blazer, 2003; Fiske, 
Wetherell, & Gatz, 2009; Pearson, 2013). Furthermore, as much as the physiological 
symptoms of dyspnea and fatigue can be incapacitating, some findings suggest that 
comorbid depression in COPD may have an even greater impact on functional capacity 
(Aydin & Ulusahin, 2001; Kim et al., 2000), treatment adherence (DiMatteo, Haskard, & 
Williams, 2007; Dowson, Town, Frampton, & Mulder, 2004), quality of life, length of 
hospital stay (Yellowlees, Alpers, Bowden, Bryant, & Ruffin, 1987), risk of exacerbation 
(Laurin et al., 2009) and even mortality (de Voogd et al., 2009). 
 
Summary and Gaps in the Literature to be Addressed by the Present Study 
In summary, COPD is prevalent and poses a significant economic and social burden. 
PR is key to optimal management and its benefits derive mainly from attending exercise 
sessions, complying to the aerobic exercise prescribed, and maintaining regular exercise 
following completion of supervised PR. Adequate exercise levels are not achieved by a 
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large majority of the general population, and this is an even greater problem among people 
living with COPD. Studies have identified a wide range of predictors of daily physical 
activity and exercise levels in COPD and more specifically, attendance at exercise-based 
PR. A few studies have investigated predictors of exercise maintenance post PR. An 
important limitation of previous studies on predictors of “adherence” in COPD is that, to 
our knowledge, they have only measured and reported on attendance at PR exercise 
sessions. Clearly this does not provide specific information on the degree of compliance 
with prescribed exercise targets nor on predictors of exercise compliance in PR. This 
leaves a significant gap in the literature: To what degree do COPD patients comply with 
prescribed exercise when they attend PR and what predicts this compliance (or non-
compliance)? Identifying and understanding the factors that impede and facilitate 
attending PR, complying with the exercise prescribed in PR, and maintaining regular 
exercise afterwards is essential to optimizing PR programs and outcomes for COPD. 
Identifying determinants of exercise compliance is essential for accurately assessing 
patients at risk for physical inactivity and for developing effective interventions that 
successfully promote self-managed exercise maintenance, thus reducing the burden that 
inactivity places on the patient with COPD, their family, and the health-care system.  
 
Primary Objectives 
The primary objectives of the present study is to investigate the extent to which 
baseline levels of depressive symptoms can predict COPD patients’ 1) attendance at 
exercise sessions during a 12-week supervised PR program, 2) compliance with the 
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prescribed duration and intensity of PR endurance exercise regimens, and 3) level of 
exercise maintained 9-months after termination of the supervised PR program.  
 
Primary Hypotheses 
Greater baseline depressive symptomatology will predict 1) lower PR exercise 
session attendance, 2) lower compliance with the prescribed aerobic exercise regimen, and 
3) lower levels of exercise maintained 9 months after termination of the PR program. 
 
Secondary Objectives 
The secondary objectives of this project are exploratory in nature and are being 
pursued with the goal of generating hypotheses for further research and confirming or 
contradicting previous findings. The first secondary objective is to identify variables, in 
addition to baseline depression, that predict PR attendance, PR exercise compliance, and 
levels of exercise maintained post PR. We are interested in investigating whether each of 
these outcomes might have different sets of predictors. Another secondary objective is to 
identify any significant differences between participants who complete the 1-year study 
and those who dropout (i.e., do not attend the follow-up evaluation).
  
Methods
  
Study Design 
This was a prospective observational study which was embedded in a randomized 
parallel-group clinical trial that compared the effects of three different aerobic exercise 
training protocols on various outcomes among COPD patients (clinical trial registration 
number: NCT01933308). The present study included three assessment periods: the first 
just prior to the start of a 12-week pulmonary rehabilitation program (baseline), the second 
was over the duration of the PR program, and the third at 9-months post PR (follow-up). 
The study was approved by the research ethics committee of Hôpital du Sacré-Coeur de 
Montréal (HSCM, see form in Appendix A) and all participants signed informed consent.  
 
Participants 
COPD patients, referred by a pulmonologist for PR, were recruited from the COPD 
Clinic at HSCM between October 2008 and June 2011. Thirty-six met eligibility 
requirements, provided informed consent, and were enrolled in this study (see Figure 2). 
Patients were eligible if they: 1) had a diagnosis of COPD confirmed by their medical 
record; 2) were clinically stable; 3) were aged  40 years; 4) had a smoking history of  
10 American pack-years (20 cigarettes per pack); 5) had post-bronchodilation forced 
expiratory volume in the first second (FEV1) of < 80 % of the predicted normal value, and   
an an FEV1 to forced vital capacity (FVC) ratio of < 0.7. Patients were excluded if they: 
1) had experienced an exacerbation of respiratory symptoms in the previous 4 weeks 
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Figure 2. Participant flow.
Assessed for eligibility (n=187) 
Excluded (n=115) 
 Did not meet initial inclusion criteria (n=48) 
 Declined to participate (n=67) 
Underwent baseline evaluations (n=72) 
 
Excluded (n=36) 
 O2 desaturation or unable to obtain ventilatory 
  threshold during incremental cycling test (n=17) 
 Other reasons (n=19) 
Randomized (n=36)  
 
Constant Training at 
Ventilatory Threshold 
 Allocated to 
intervention (n=12)                
 Received allocated 
intervention (n=12) 
 
 
Constant Training at 
80% of Peak Work Rate 
 Allocated to 
intervention (n=12) 
 Received allocated 
intervention (n=12) 
Interval Training 
 Allocated to 
intervention (n=12) 
 Received allocated 
intervention (n=12) 
 
 
Lost to follow-up (n=0) 
 
 
Lost to follow-up (n=2): 
Participants did not return 
for follow-up evaluations 
 Multiple imputation was 
used to derive their 
outcome data (n=2) 
 
Lost to follow-up (n=6): 
Participants did not return 
for follow-up evaluations 
 Multiple imputation was 
used to derive their 
outcome data (n=6) 
 
 
Analyzed (n=12) 
 Excluded (n=1) from 
some analyses because 
found to be a 
multivariate outlier 
 
 
 
 
Analyzed (n=12) 
 
 
 
Analyzed (n=12) 
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(defined as change in dyspnea or volume/color of sputum, need for antibiotic treatment, 
or need for hospitalization); 2) had any contraindication to exercise testing based on 
American Thoracic Society guidelines (American Thoracic Society & American College 
of Chest Physicians, 2003); 3) had any active condition other than COPD that could affect 
their exercise tolerance (e.g., asthma, unstable coronary heart disease, left congestive heart 
failure, neoplasia, severe claudation, arthritis, etc.); 4) required supplemental oxygen; 5) 
had participated in a PR program in the previous year; or 6) were unable to complete 
baseline evaluations (e.g., unable to achieve a ventilatory threshold on the incremental 
cycling test or to speak/understand English or French adequately). These eligibility criteria 
were intended to differentiate COPD from other respiratory diseases and to ensure clinical 
stability and patient safety. 
 
Procedure 
As shown in Figure 3, eligible patients underwent baseline assessments, including a 
sociodemographic and health questionnaire, spirometry, exercise testing, psychological 
and socio-cognitive measures. Once six patients had completed assessments, they were 
randomly assigned as a group to one of three aerobic training regimens and enrolled into 
the PR program, which took place at the Hospital’s cardiopulmonary rehabilitation center, 
Centre de réadaptation cardio-respiratoire Jean-Jacques-Gauthier. Six consecutive 
groups, each comprised of six participants underwent supervised PR at a frequency of 
three sessions per week over 12 weeks for a total of 36 sessions. Six participants at a time 
followed the same exercise protocol because of contamination concerns: differential 
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exercise intensity among participants in the same group could have potentially affected 
participants’ motivation to comply with the demands of their own exercise prescription. 
Also, it optimized the efficiency of exercise supervision, while respecting the 
recommended staff to patient ratio of no less than 1 to 8 (Nici et al., 2006). The PR 
program consisted of endurance exercise training, strength training, stretching, and 
education about COPD and disease self-management based on the Living Well With 
COPD program (Bourbeau et al., 2006). Once two groups had been randomized to a 
particular exercise protocol, that protocol was removed from the list to ensure equal 
allocation of 12 participants to each exercise regimen. During the PR program, attendance 
and exercise compliance was recorded. At the end of each PR program, participants were 
instructed to continue exercising autonomously at home and/or in the community at the 
same level of intensity and duration as during their final week of PR. Follow-up 
assessments were done 9-months post-PR to measure level of exercise engaged in over a 
1-week period. Participants received 50 dollars for each assessment visit. 
 
 
 
 
 
 
Figure 3. Study overview.
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Exercise Training Protocols 
The endurance exercise training program consisted of cycling on a calibrated cycle 
ergometer. A 10-minute warm-up phase (5 minutes of unloaded pedaling followed by 5 
minutes of pedaling against incremental resistance up to attainment of the target training 
intensity) preceded the active training phase. For the training phase, participants were 
instructed to exercise within  five beats per minute of their prescribed target heart rate 
(THR) for the duration of each aerobic exercise session. The THR value was determined 
by the exercise regimen (constant training at the ventilatory threshold [CTVT], constant 
training high intensity [CTHi], or interval training [IT]), and was calculated for each 
participant based on measures from their baseline symptom-limited incremental cycling 
test which determined their work load at peak effort and at the ventilatory threshold. 
 
Participants in the CTVT group trained at a heart rate corresponding to their 
ventilatory threshold, which is of moderate intensity and commonly described as the 
breakpoint in the ventilatory response to incremental exercise above which minute 
ventilation increases disproportionately in response to increments in oxygen consumption 
(Beaver, Wasserman, & Whipp, 1986; Vallet et al., 1997).  Training at the ventilatory 
threshold has been associated with tolerable levels of ventilation and dyspnea (Gallagher, 
1994; Potter, Olafsson, & Hyatt, 1971). The ventilatory threshold does not occur at the 
same percentage of peak capacity for all individuals, and was thus determined on an 
individual basis with the incremental cycling test performed at baseline. Participants in 
the CTHi group were prescribed a THR equal to that which occurred at 80 % of their peak 
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wattage during their pre-PR incremental test. The duration for CTHi was 25 minutes. The 
IT condition was comprised of a 30-second training phase during which participants were 
instructed to exercise at the heart rate corresponding to 100 % of their peak wattage for 
30 seconds, interspersed with 30 second periods of active recovery (unloaded pedaling) 
for a specified total training duration (Vogiatzis et al., 2002). Training duration for CTVT 
and IT was adjusted using metabolic equations (American College of Sports Medicine, 
2006) such that the total amount of work was equivalent to what each participant would 
have performed if he/she had been assigned to the CTHi group, thereby isolating the effect 
of training intensity from that of the total training dose (Casaburi et al., 1991). (These 
exercise conditions were the exposure for the study (in which the present study was 
embedded) whose main objective was to determine the optimal aerobic exercise-training 
regimen for COPD rehabilitation.  
  
Training intensity was ascertained with a heart rate monitor and transmitter (T31 
transmitter, Polar®, Finland) that displayed heart rate to participants, thus providing 
feedback throughout exercise sessions so that participants could constantly monitor and 
adjust their pedaling speed to maintain their heart rate within the prescribed range (a 
“beep” sounded when heart rate went below the target range). A 5-minute cool-down 
phase consisting of unloaded pedaling followed each training phase. 
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Baseline Measures 
Socio-Demographic Data  
A research assistant collected socio-demographic information (age, weight, marital 
status, years of education, smoking status and history, and comorbidities) by interview 
and from participants’ medical chart. 
 
Pulmonary Function Tests  
Expiratory flow rates (FEV1), lung volumes (FVC), were among measures obtained 
with standard spirometry according to recommended techniques (American Thoracic 
Society, 1995). Values were compared to predicted normal values from the European 
Community for Coal and Steel/European Respiratory Society (Quanjer et al., 1993). 
 
Incremental Cycling Test  
Patients performed a symptom-limited incremental cycling test to determine their 
work rate at peak effort and at the ventilatory threshold. These values were used to 
determine subsequent exercise intensity prescription for PR and to rule out the presence 
of cardiovascular comorbidities. Participants were seated on an electromagnetically 
braked cycle ergometer (Ergometrics 800, SensorMedics, Yorba Linda, CA) and were 
connected to an electrocardiogram and respiratory circuit through a mouthpiece. The 
respiratory circuit consisted of a pneumotachograph, digital volume sensor, O2 and CO2 
analyzers, and a mixing chamber (Vmax Encore, Sensor Medics, Yorba Linda, CA). After 
five minutes of rest and three minutes of unloaded pedaling, the workload was increased 
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in a stepwise manner up to the individual’s maximal capacity. Each step lasted one minute 
and increments of 5-10 watts were used (5-watt increments for participants with a 
predicted peak work rate < 50 watts; 10-watt increments for those with a predicted peak 
work rate > 50 watts). This protocol is frequently used in respirology (N. L. Jones, 
Makrides, Hitchcock, Chypchar, & McCartney, 1985) . Gas exchange parameters (minute 
ventilation, O2 uptake, CO2 excretion) and heart rate were measured at rest and during 
exercise on a breath-by-breath basis. The ventilatory threshold was determined using the 
V-slope method (Beaver et al., 1986), a computerized approach to identify the breakpoint 
in the carbon dioxide secretion – oxygen consumption relationship. Peak work rate was 
defined as the highest work rate the participant could maintain at a pedaling speed of at 
least 50 revolutions per minute for a minimum of 30 seconds. This test was completed 
under medical supervision. 
 
Psychological Measures  
 The Beck Depression Inventory–II. The Beck Depression Inventory–II (BDI-II) 
is a widely used self-report instrument administered to assess the presence and severity of 
symptoms of depression (the primary predictor in this study), as described in the 
Diagnostic and Statistical Manual of Mental Disorders, fourth edition (American 
Psychiatric Association, 1994). Twenty-one items assessing symptoms of depression are 
rated using descriptors of increasing severity (range 0-3), producing a summary score 
ranging from 0 (no symptoms) to 63 (maximum symptoms) with cut-off values for distinct 
levels of severity. A cut-off score of 14 is considered the threshold for “mild” clinical 
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depression (Beck, Steer, & Brown, 1996) in the general population, with some variation 
found in specific clinical populations (Wang & Gorenstein, 2013b). The BDI-II has been 
used across a broad spectrum of psychological and medical conditions and has been found 
to have very good reliability and validity (Wang & Gorenstein, 2013a). The French 
translation used in the present study has maintained the sound psychometric properties of 
the original instrument (Bourque & Beaudette, 1982; Corbiere et al., 2011; Vézina, 
Landreville, Bourque, & Blanchard, 1990). 
 
  The Multidimensional Health Locus of Control Scale – Form C. The 
Multidimensional Health Locus of Control Scale – Form C (HLC) assesses beliefs about 
where control and responsibility for one’s health lies: internal/personal or external 
orientation (Wallston et al., 1978). It is an 18-item self-report scale that is adaptable for 
use with any specific health-related condition (form C), and is comprised of four distinct 
scales - Internal, Chance, Doctors, and Other People - each yielding its own score. 
Responses are indicated on a 6-point Likert scale that ranges from strongly disagree to 
strongly agree. The HLC has shown ample internal consistency reliability for the four 
scales with Chronbach alphas ranging from 0.70 to 0.82 (Wallston et al., 1994). In a study 
with 186 asthma patients, Chronbach’s alpha coefficients for the four scales ranged from 
0.71 to 0.74 (Dupen, Higginbotham, Francis, & Cruickshank, 1996). Each of the four 
scales of the HLC correlated significantly (p < .001) with the same subscales of the 
Multidimensional HLC Form B, thus supporting its criterion-related validity (Wallston et 
al., 1994). In arthritis and chronic pain samples, the Internal Scale showed a significant 
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negative correlation to pain and helplessness measures, while the Chance Scale showed a 
significant and positive correlation to measures of depressive symptoms and helplessness, 
thereby supporting the HLC’s construct validity (Wallston et al., 1994). No validated 
French version of the HLC Form C was found, therefore the English HLC was translated 
into French and then back translated to English by bilingual members of the study team. 
As such, only psychometric data available for the English version are presented. 
 
Measures Taken During the PR Program 
PR Exercise Attendance  
In this study PR attendance was recorded was calculated as the ratio of endurance 
exercise sessions attended to total number of sessions offered (i.e., 36), multiplied by one 
hundred to produce a percentage value.  
PR Exercise Compliance  
The measure of compliance with the aerobic exercise prescription was calculated as 
the total time during which each participant exercised within or above their target heart 
rate range (plus or minus five beats per minute of prescribed target heart rate) divided by 
the total duration of aerobic exercise sessions prescribed, multiplied by one hundred to 
produce a percentage value. Each participant’s heart rate was measured during every 
aerobic training session (for which they were present) with continuous data tracking on a 
second-by-second basis using both hardware (Bike Excite Med 700, Technogym®, Italy; 
and T31 transmitter, Polar, Finland) and computer software (CardioMemory® by 
Technogym, Italy, 2006).  Heart rate (as opposed to watts) was chosen as the measure of 
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compliance with the exercise prescription because heart rate response at a given 
submaximal workload decreases as cardiorespiratory fitness increases, therefore this 
approach ensured that patients would remain at the same relative (versus absolute) training 
intensity throughout the PR program’s duration. Compliance for each participant was 
calculated only from the PR exercise sessions for which he or she was present.     
 
PR Composite Adherence 
Finally, because we had both attendance and exercise compliance data, it was 
possible to calculate a “composite adherence” measure for PR as the product of attendance 
and compliance with the prescribed exercise target (% attendance  % compliance). 
Composite adherence may be useful from a clinical standpoint because it captures in a 
single measure the two essential aspects of PR exercise adherence. However, it was not a 
central focus of this study (in terms of predictors), as more valuable information could be 
gained by investigating the rates and predictors of PR attendance and exercise compliance 
separately as opposed to if they had just been combined; i.e., composite  adherence.  
 
Follow-Up Measure 9-Months Post PR 
Nine months post-PR, patients were asked to complete a 7-day physical activity 
diary at the end of each day, which was based on the Seven-Day Physical Activity Recall 
(Blair et al., 1985; Garfield et al., 2012; Sallis et al., 1985). They were instructed to 
document up to three physical activities per day that they had engaged in (continuously 
for a minimum of 10 minutes each), the duration, and to rate the subjective intensity of 
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each as “light,” “moderate,” or “high” (see the diary in Appendix E). To obtain the follow-
up measure, activities were divided into exercise/sport activities (e.g., walking, cycling), 
and activities of daily living (e.g., housework, shopping, meal preparation). Only the 
exercise/sports activities were retained to calculate exercise levels at follow-up because 
of the inconsistency within and between participants’ recording their activities of daily 
living (i.e., showering, cooking, and house cleaning were documented by some 
participants but not by others who presumably had also done some of these activities). 
The Compendium of Physical Activities (Ainsworth et al., 2011) lists a vast number of 
highly specific physical exercises and activities and provides ratings on the energy 
expended for each in Metabolic Equivalent of Task units (METs). One MET is the amount 
of energy expended by an individual while seated at rest. The MET value while exercising 
is a ratio of that amount of energy being expended compared to that while seated at rest 
(1 MET), for example; walking at a moderate pace on level ground has a MET value of 
3.5 meaning that the energy being expended is 3.5 times greater than the energy being 
expended at rest (3.5/1 METs). Using the Compendium, every activity recorded in the 7-
day diary was assigned its METs value and was then multiplied by the activity’s duration 
in minutes to produce a MET-minutes value for each (American College of Sports 
Medicine, 2006; Bushman, 2012) . These were then summed to obtain a MET-minutes 
total which was the volume of exercise for the week and served as our follow-up outcome.  
 
Adverse Events 
COPD exacerbations occurring during the study were noted and participants were 
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recommended to: 1) follow their action plan; 2) contact a member of the study personnel; 
3) refrain from exercising if necessary; and 4) resume exercising as soon as possible. Other 
medical problems were also noted. No injuries or medical problems resulted from 
undergoing PR. 
 
Data Screening and Management 
Extreme Values 
Extreme scores in the dataset were identified and checked against the values in the 
original source documents to ensure they had been entered correctly. Discrepancies were 
resolved by retaining the values from the source documents, unless they were outside the 
possible range, in which case they were entered as missing. When an extreme univariate 
outlier (extreme value on one variable) or multivariate outlier (unusual score on a 
combination of two or more variables, such as with correlations or regressions) was 
identified, statistical analyses were conducted that included the extreme outlier and were 
then repeated with the outlier winsorized (for univariate outliers) or excluded (for 
multivariate outliers) (Field, 2013; Lang & Secic, 2006). These results were compared and 
if an outlier was found to exert substantial influence, results from the analyses in which it 
had been transformed or excluded were considered to be more valid or representative of 
our relatively small sample (Appendix C contains normality assessments).  
 
Missing Values  
In accordance with intention-to-treat analysis, no cases with missing data were 
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removed from the data set. Missing baseline and follow-up values were assessed for 
frequency and patterns (degree of randomness) using SPSS 23 Missing Values Analysis 
and were then imputed using the SPSS Multiple Imputation Procedure (IBM, 2013), as 
described in Appendix D and Table 38. Missing exercise compliance data had already 
been imputed in the larger study’s statistical procedures and were retained in the present 
study for purposes of consistency: when a participant’s compliance data were missing for 
an entire exercise session (due to technical failures to record, store, or retrieve data), values 
from that participant’s previous exercise session were carried forward. When only a 
segment of a participant’s exercise session data was missing, exercise compliance was 
calculated from the values that had been obtained for that session. 
 
Use of Bootstrapping  
Bootstrapping based on 1000 samples employing the bias-corrected and accelerated 
(BCa) method to construct confidence intervals was used in all regression analyses 
because of: 1) the modest sample size, 2) the non-normal distribution of some data, and, 
3) failure to meet some assumptions for multiple linear regression (e.g., homoscedasticity, 
normal distribution of residuals). This helped produce robust confidence intervals, 
standard errors, and p values. All potential IVs for correlation and linear regression 
analyses were screened for collinearity and multicollinearity and if found, only the 
variable with the stronger association to the outcome variable was retained in analyses 
(Tabachnick & Fidell, 2013).  
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Statistical Analyses 
Data were analyzed using the Statistical Package for the Social Sciences version 
23.0 software (SPSS 23, Chicago, IL, USA). All tests of significance were two-sided and 
alpha level was set at p < .05. 
 
Descriptive Statistics 
Following data screening, descriptive statistics of our sample’s characteristics were 
compiled. Normally distributed quantitative data were described with means and standard 
deviations (SDs); while data with non-normal distributions were characterized with their 
medians and interquartile ranges (IQR) in addition to their means and SDs. Categorical 
data were described with n and percentages. 
 
Univariate Prediction of Outcomes 
Pearson correlations were used to characterize the relationship between baseline 
BDI-II scores and each of the outcome variables (PR attendance, PR exercise compliance, 
and exercise levels at follow-up). Categorical variables (e.g., exercise protocol, sex) were 
converted using dummy variable coding so that they could be incorporated into the 
multiple linear regression analyses (Field, 2013). Pearson correlations were also 
performed to check levels of collinearity between all independent variables. 
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Multivariate Prediction of Outcomes 
Multivariate prediction using standard linear regressions was carried out for both 
our primary and secondary (exploratory) analyses. For the primary analysis, baseline BDI-
II was the predictor of interest for each of our three outcomes: PR attendance, PR exercise 
compliance, and levels of autonomous exercise maintained at follow-up. Five covariates 
(IT and CTHi exercise interventions with CTVT chosen as the reference [as it was a 
constant and stable exercise regimen with the lowest intensity] , sex, baseline FEV1 %, 
and baseline smoking status) were selected a priori for inclusion to adjust for their 
potential confounding effects. Because the present study was embedded in a trial 
comparing the effects of three exercise interventions, it was decided a priori that these 
exercise interventions be included as covariates in the analyses to account for possible 
differential effects on the outcomes. The other covariates were chosen based on their 
clinical relevance and their emergence in prior research findings. Furthermore, we 
checked for moderation and mediation in our primary regression analyses by identifying 
any significant interactions among BDI-II and covariates using PROCESS procedure 
macro for SPSS (Hayes, 2014). 
 
Our secondary analyses were exploratory and sought to construct the regression 
models that could best predict each outcome by including the strongest (and fewest 
number of) independent predictors of each outcome (Harrel, 2001). The objective was to 
identify the sets of variables that could best predict each outcome and to determine 
whether those sets were different for PR attendance, PR exercise compliance, and levels 
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of exercised maintained at follow-up. Given the relatively small sample size (N = 36) and 
large number of baseline demographic, clinical, and psychological/socio-cognitive 
variables, only a few predictors could be included in the regression analyses, otherwise 
over fitting would occur, thus compromising the validity of the outcomes. It was decided 
a priori that the ratio of cases to predictors would be no less than seven to one for our 
exploratory regression analyses. The selection of predictors for each model was based on: 
strength of Pearson correlations between IVs and each of the three outcomes (see 
Appendix E, Table 39), significant covariates that emerged in the regressions from our 
primary analyses, clinical relevance, and findings of previous studies. 
 
Comparison of Study Completers Versus Dropouts 
Differences in the characteristics of participants who attended the follow-up 
evaluations (“completers”) and those who were absent (“dropouts”) were examined using 
Mann-Whitney U tests (for continuous data) and Pearson chi-square tests (for categorical 
data). The Mann-Whitney U test was chosen because of: 1) the small sample size, 2) 
unequal size groups of completers present and dropouts, and 3) some variables (predictors 
and outcomes) having non-normal data distributions. 
  
Results
  
Missing Data 
Only 0.06 % of all baseline values was missing and this was completely at random 
(Little’s MCAR test: Chi-Square = 15.17, DF = 39, p = 1.000). No PR attendance data 
were missing and only 0.80 % of all the PR exercise compliance data was lost due to 
exercise equipment or computer problems or human error. This included just two entire 
exercise sessions out of 899 (0.22 %) for which the values of the previous session were 
carried forward. For the follow-up data (MET minutes of exercise 9-months post-PR) 11 
values (30.56 %) out of 36 were missing: eight participants did not return for follow-up 
evaluations and for the 28 who did, one did not submit their physical activity diary, while 
two others submitted diaries lacking information required for scoring. The 11 missing 
values were imputed using the Impute Missing Values procedure in SPSS version 23.0 
(see Appendix D for a detailed description and results of this procedure.)   
 
Participants 
Baseline characteristics of the 36 study participants are presented in Table 1. The 
sample had a mean age (SD) of 68 (9) years, tended to be overweight, nearly two thirds 
were female, and one third (no males) lived alone. The mean (SD) smoking history was 
42 (13) American pack-years (20 cigarettes per day), and one third of participants were 
smoking at baseline. Eighty-six percent of participants had COPD in the moderate (55%) 
to severe
  
Table 1 
Baseline Characteristics of Participants 
Sociodemographic 
      Age, years 68 (9)  
      Female 23 (64 %)  
      BMI, kg/m2 28 (5)  
           Underweight   0 (0 %)  
           Normal weight 14 (39 %)  
           Overweight 10 (28 %)  
           Obese 12 (33 %)  
      Cumulative Smoking, pack yearsa 42 (13)  
      Smoking at Baseline 12 (33 %)  
      Cohabitingb 24 (67 %)  
Pulmonary Function   
      FEV1, litres   1.4 (0.4)  
      FEV1 % predicted 59 (17)  
      FEV1/FVC % 50 (9)  
      GOLD stage (FEV1 % predicted)   
            1. Mild (≥ 80%)   3 (8 %)  
            2. Moderate (50%-79%) 20 (55 %)  
            3. Severe (30-49%) 11 (31 %)  
            4. Very severe (< 30%)   2 (6 %)  
Psychological  Median (IQR)c 
      BDI-II (scale 0-63)   9.4 (6.6) 8.5 (6–13) 
      HLC Internal orientation   
            Internal (0-6)   4.1 (1.2) 4.5 (3.5–5.0) 
      HLC External orientation   
            Chance (scale 0-6)   2.7 (0.9)  
            Doctor (scale 0-6)   5.0 (1.4) 5.3 (4.8–6.0) 
            Other People (scale 0-6)   3.0 (1.4)  
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Note. N = 36. Data are means (SD) or n (%) unless otherwise indicated. BMI = body mass index; 
FEV1 % predicted = forced expiratory volume in 1st second percent of predicted normal value; 
FVC = forced vital capacity; GOLD = Global Initiative for Chronic Obstructive Lung Disease; 
IQR = interquartile range; BDI-II = Beck Depression Inventory-II; HLC = Health Locus of 
Control. 
aU.S. pack years (20 cigarettes per pack). bLiving with at least one other person. cMedian (IQR) 
are presented when data distribution is skewed. 
 
 
(31%) range as per the GOLD classification. Locus of control for health tended to be 
doctor and internally oriented, while a chance orientation received the lowest rating. 
 
Depression  
The sample’s median baseline BDI-II score was 8.5 indicating that this sample had 
generally subclinical levels of depressive symptomatology. Figure 4 shows the 
distribution of baseline BDI-II scores, which was positively skewed and had one extreme 
outlying high score (35, z = 3.85, p < .001; see table 12 in Appendix C for normality 
assessment). The dashed line marks the threshold score of 14 for clinical depression, and 
five scores equaled or exceeded this threshold. Winsorizing was used to help reduce the 
potential impact (bias) of this univariate outlier (Field, 2013; Tabachnick & Fidell, 2013): 
the outlying value of 35 was brought closer to the center of the distribution by reducing it 
to 23 (z = 2.51, see Table 12), still two units greater than the next highest score and 
equivalent to the 95th percentile. 
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Figure 4. Baseline BDI-II data with threshold for clinical depression. 
 
 
Outcome Variables 
As shown in Table 2, median attendance at PR exercise sessions was generally high, 
as was median exercise compliance, which was reflected in their negatively skewed data 
distributions (see Figure 5 and table 13). Median composite adherence was lower, as 
would be expected given that it is the product of attendance and exercise compliance and 
as such reflected the deficits of each. Total amounts of exercise for a 1-week period at 
follow-up had a median of 706 MET-minutes (N = 36, 11 missing values imputed). This 
is equivalent to walking on a level surface at a leisurely pace of 4 KMs hour for about 4 
hours (distance of 16 KMs), but it fell short of the median (IQR) prescription of 842 (781–
911) MET minutes per week (equivalent to a distance of almost 19 KMs and a duration 
of almost 5 hours) for ongoing autonomous exercise, which was based on the amount of 
exercise performed over their last three PR sessions; 58 % of participants failed to meet 
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their target weekly exercise levels. In contrast to PR attendance and compliance, the 
follow-up data were positively skewed (see Figure 5 and Appendix C Table 14). 
 
Table 2 
Outcome Measures 
Outcomes Median (IQR) M (SD) 
PR Attendance % 83 (67–94) 74 (28) 
PR Exercise Compliance % 94 (71–99) 76 (34) 
PR Composite Adherence %a 72 (29–86) 57 (33) 
Exercise Level at Follow-up, 
MET minutes 
   706 (445–1146) 919 (739) 
Note. N = 36. IQR = interquartile range; PR = pulmonary rehabilitation; MET = metabolic 
equivalents of task; mins. = minutes. 
a PR composite adherence is the product of PR % attendance  PR % exercise compliance 
 
 
 
    
Figure 5. Distributions of PR attendance, PR exercise compliance, and follow-up 
exercise levels (N = 36).   
 
Thirty-six participants were each offered 36 endurance exercise sessions for a grand 
total of 1296 potential sessions. In all, 34 participants missed a total of 333 PR sessions 
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(25.7 % of total sessions offered). The reasons for missed PR sessions were documented 
and are presented in Figure 6 below, as a percentage of the total sessions missed. 
 
 
Figure 6. Reasons and their respective proportions for missed PR sessions. “Dropout” values (n 
= 71 of 333) are for two participants who discontinued the PR program shortly after it began. 
 
 
Correlations 
The relationships between baseline depressive symptomatology and each outcome 
are depicted in Figure 7. Baseline BDI-II and PR attendance had almost no relationship; 
variation in baseline depressive symptomatology accounted for only 0.04 % of the 
variation in PR attendance. Figure 7A reveals a high outlying BDI-II score (see Tables 15 
and 16 in Appendix C for normality/bias assessments), and when it was winsorized (Field, 
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2013) from 35 to 23 (reduced to the value corresponding to the 95th percentile), the 
relationship was found to be even weaker (r = .00, BCa CI [-.26, .24], p = .999). 
 
    A.     B. 
      
N = 36, Pearson r = .02, p = .918                       N = 36, Pearson r = -.35, p = .037 
 
  C.     D. 
       
 N = 36, Pearson r = -.28, p = .103      N = 35, Pearson r = -.58, p < .001  
       
Figure 7. Relationships between baseline depression and each outcome: (A) PR attendance, (B) 
PR exercise compliance, (C) exercise levels at follow-up with the high outlying BDI-II score and 
multivariate outlier included and, (D) exercise levels at follow-up with the high BDI-II 
winsorized (from 35 to 23) and the multivariate outlier removed. 
 
Baseline BDI-II and PR exercise compliance were weakly negatively associated, 
with variation in the former accounting for 12.3 % of the variation in the latter. Again, the 
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impact of the outlying high baseline BDI-II score was assessed by winsorizing it and 
repeating the correlation, which then yielded a Pearson r of -.29 (p = .086) where variation 
of baseline BDI-II scores accounted for 8.4% of the variation in PR exercise compliance. 
This was a weaker and statistically non-significant negative association compared to that 
which included the outlying BDI-II score, suggesting that the outlier exerted substantial 
influence over the r statistic (see bias assessments in Appendix C Tables 17 and 18). 
Therefore, the r value based on the less extreme BDI-II score (23 instead of 35), more 
accurately portrayed the relationship between baseline depressive symptomatology and 
PR exercise compliance for the majority of this sample, was less likely to produce a type 
I error, and was likely a more generalizable result (Field, 2013; Tabachnick & Fidell, 
2013). 
 
Only a weak and statistically non-significant negative correlation emerged between 
baseline BDI-II and composite PR adherence, and this was the case whether the BDI-II 
outlier winsorized or not (more details are presented in Appendix F, Figures F1 and F2). 
 
The scatterplot depicting the relationship between baseline BDI-II scores and 
participants’ exercise levels at follow-up is shown in Figure 7C above. It reveals an 
influential bivariate outlier with high discrepancy and leverage (standardized residual = 
3.49, see normality assessments in Appendix C Table 19) who had the second highest 
baseline BDI-II score and the highest exercise level of all participants at 9-months post 
PR. This profile is contrary to the trend displayed by the other participants and had a 
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disproportionate impact on the Pearson correlation coefficient. With this outlier in the 
analysis, the sample’s baseline depressive symptomatology (BDI-II) had a weak and 
statistically non-significant negative association with exercise levels at follow-up, with 
variation in baseline depressive symptomatology accounting for only 7.6 % of the 
variation in exercise levels at follow-up. However, when the analysis was conducted with 
the bivariate outlier removed and the high (outlying) BDI-II score winsorized, the negative 
relationship was moderately strong (r = -.58, p < .001), indicating that as baseline 
depressive symptomatology increased, exercise levels at follow-up decreased. Variation 
in baseline BDI-II accounted for 33.6 % of the variation in exercise levels making BDI-II 
the strongest single predictor among all baseline variables of exercise levels at follow-up. 
This more accurately represents the baseline BDI-II – follow-up exercise relationship for 
35 of 36 participants in this sample, as removing the bivariate outlier substantially reduced 
bias and improved the normality and generalizability of the model (see Tables 20 - 22 in 
Appendix C).  
 
Primary Multivariate Analyses 
Standard multiple regression analyses were performed to test the hypotheses that 
higher baseline BDI-II scores (depressive symptomatology), within the context of the five 
selected covariates, predicted 1) lower PR attendance, 2) lower PR exercise compliance, 
and 3) lower levels of exercise sustained at follow-up. For all regression analyses, the 
extreme high outlying BDI-II score was winsorized (reduced to a value two units greater 
than the next highest score, and at the 95th percentile), as the outlier introduced substantial 
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bias, reduced generalizability, and increased the likelihood of type I errors. Bootstrapping 
was used because assumptions of normality and homogeneity of variance for residuals 
were violated (see Appendix C Tables 23 – 30). 
 
First, regression analysis was performed with PR attendance as the outcome, 
baseline BDI-II as the main predictor and the five covariates. As can be seen in Table 3, 
the full regression model did not predict PR attendance significantly better than if its mean 
alone had been used; F (6, 29) = 1.96, p = .105.  
 
Table 3 
 
Multiple Regression Model for Prediction of PR Attendance 
 by Baseline BDI-II with Covariates 
  Bootstrapa 
Variable      B          ß           SE B p 95 % CI for Bb 
Constant 33.20  23.34   .174 [-11.48, 85.39] 
bBDI-II   0.59  .12   0.87   .478 [-1.37, 1.85] 
IT  -4.02 -.07 13.24   .764 [-29.79, 17.51] 
CTHi   2.79   .05 11.23   .803 [-19.74, 28.72] 
Sex (F) -17.88 -.32   8.57   .051 [-34.88, -3.41] 
bFEV1 %   0.79   .49   0.30   .018 [0.20, 1.30] 
bSmoking   1.90   .03 10.34   .851 [-18.87, 23.91] 
Regression Model        R = .54        Adjusted R2 = .14        F (6, 29) = 1.96, p = .105 
Note. N = 36. CI = confidence interval; bBDI-II = baseline Beck Depression Inventory-II; IT = 
interval training; CTHi = constant training high intensity; bFEV1 % = baseline forced expiratory 
volume in the first second percent of predicted normal value; bSmoking = smoking at baseline. 
aBootstrap results are based on 1000 bootstrap samples. bConfidence intervals are bias-corrected 
and accelerated. 
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Baseline BDI-II did not emerge as a significant independent predictor of PR attendance. 
FEV1 % was the only covariate that had a statistically significant positive association to 
PR attendance, while sex reached borderline significance (female sex was associated with 
lower PR attendance).    
 
Standard multiple regression was next performed on PR exercise compliance as the 
outcome, baseline BDI-II as the predictor of interest, with the same covariates as above. 
Table 4 below reveals that the full model was effective at predicting compliance, F (6, 29) 
= 6.34, p < .001. Baseline BDI-II emerged as a significant independent predictor when 
effects of the covariates were held constant: higher baseline depressive symptomatology 
predicted lower compliance with exercise intensity in PR. Covariates significantly 
associated with lower exercise compliance were the IT exercise protocol, higher FEV1 % 
predicted, and Sex (male). Because exercise compliance scores were calculated only from 
the sessions attended, we realized that this may have introduced bias; i.e., what if exercise 
compliance measured over many exercise sessions (say > 30) tended to be lower (or 
higher) than that measured over fewer (say < 10) sessions simply because it was more 
likely over many exercise sessions to fall below the target intensity? In order to verify this 
possibility, a correlation was performed between PR attendance and PR exercise 
compliance. This yielded a Pearson r of .11 (p = .51) which showed that PR attendance 
accounted for only 1.2% of the variance in exercise compliance and showed that the 
number of exercise sessions upon which exercise compliance scores were based had 
virtually no influence on participants’ compliance scores. 
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Table 4 
 
Multiple Regression Model for Prediction of PR Exercise Compliance  
by Baseline BDI-II with Covariates 
  Bootstrapa 
Variable   B         ß           SE B   p 95 % CI for Bb 
Constant 141.94  20.13   .001 [101.50, 181.17] 
bBDI-II -2.49 -.40   1.05   .047 [-4.76, -0.18] 
IT -54.89 -.77 12.56   .004 [-79.57, -27.20] 
CTHi -10.27 -.14 10.43   .332 [-30.55, 7.53] 
Sex (F) 26.65  .38 11.36   .034 [1.36, 47.78] 
bFEV1 % -0.66 -.33   0.29   .039 [-1.13, -0.04] 
bSmoking 1.12  .02 10.07   .910 [-18.18, 23.07] 
Regression Model        R = .74        Adjusted R2 = .46        F (6, 29) = 5.90, p < .001 
Note. N = 36. CI = confidence interval; bBDI-II = baseline Beck Depression Inventory-II; IT = 
interval training; CTHi = constant training high intensity; bFEV1 % = baseline forced expiratory 
volume in the first second percent of predicted normal value; bSmoking = smoking at baseline. 
aBootstrap results are based on 1000 bootstrap samples. bConfidence intervals are bias-corrected 
and accelerated. 
 
A moderation model was tested using the method described by Hayes (2013) to 
determine if the relationship between baseline BDI-II (the predictor) and PR exercise 
compliance changed as a function of exercise intervention (the moderator) while adjusting 
for baseline smoking status, FEV1% predicted, and sex. This was done using the 
PROCESS procedure macro for SPSS developed by Hayes (2014). A significant 
interaction effect between baseline BDI-II and exercise intervention was found (b = -2.16, 
95 % CI [-3.30, -1.01], t = -3.86, p < .001) indicating that the relationship between baseline 
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depressive symptomatology and PR exercise compliance was moderated by exercise 
intervention (see Figure 8 below). When the exercise intervention was CTHi, there was a 
 
 
Figure 8. Baseline depression symptomatology predicting PR  
exercise compliance moderated by PR aerobic exercise intervention  
(adjusting for baseline smoking status, FEV1 % predicted, and sex). 
 
non-significant negative relationship between baseline depression symptomatology and 
PR exercise compliance, b = -0.61, 95 % CI [-2.16, 0.95], t = 0.80, p = .430. With CTVT, 
there was a significant negative relationship between baseline depression symptomatology 
and PR exercise compliance, b = -2.40, 95 % CI [-3.74, -1.05], t = -3.63, p = .001. The IT 
exercise intervention had the strongest negative relationship between baseline depression 
symptomatology and PR exercise compliance, b = -4.18, 95 % CI [-5.92, -2.45], t = -4.93, 
p <.001. (The variability of BDI scores was similar within the three exercise groups, thus 
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confirming it was the type of exercise, not BDI variability, that caused the moderation.) 
Next, composite PR adherence was regressed against baseline BDI-II and 
covariates. BDI-II was not found to be a significant independent predictor of lower 
composite adherence (see table 40 in Appendix F). Combining PR attendance and exercise 
compliance into composite adherence (outcome) resulted in the significant relationship 
between BDI-II and exercise compliance being masked by the weak relationship between 
BDI-II and PR attendance in our sample. IT exercise was the only covariate to emerge as 
a significant independent predictor of poorer composite adherence (see Table 40), but this 
was driven mainly by the exercise compliance component (see Appendix F for more PR 
composite adherence results).  
 
Finally, exercise levels at follow-up were regressed against baseline BDI-II and our 
five covariates. Verification of data revealed an extreme multivariate outlier (standardized 
residual = 3.29) that exerted substantial influence on the model (biased the parameter 
estimates and dramatically affected the sum of squared errors – see assessment of bias and 
normality in Appendix C, table 29). We therefore ran the regression analysis both with 
and without the multivariate outlier in the data set, as recommended by Field (2013) and 
Tabachnick and Fidell (2013). We believed excluding the multivariate outlier would 
produce a less biased result more representative of our sample. Table 5 displays results 
derived from data which included the outlier. It shows that the regression model accounted 
for only 19 % (adjusted R2) of the variation of follow-up exercise levels and did not predict 
significantly better than using the outcome’s mean. Baseline BDI-II did not emerge as a 
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significant predictor. Baseline smoking status had the only statistically significant 
(negative) association with post-PR exercise levels.  
 
Table 5 
Multiple Regression Model for Prediction of Exercise Levels at Follow-Up by Baseline 
BDI-II with Covariates (Multivariate Outlier Included) 
  Bootstrapa 
Variable  B         ß       SE B    p        95 % CI for Bb 
Constant 1742.89  607.51   .014 [475.32, 3065.67] 
bBDI-II -27.30 -.20   35.07   .513 [-87.55, 30.93] 
IT -175.46 .11 352.03   .623 [-1075.30, 512.86] 
CTHi -242.30 .16 344.48   .523 [-959.65, 416.89] 
Sex (F) -111.35 -.07 236.37   .635 [-663.36, 335.54] 
bFEV1 % -2.37 -.06     6.88   .716 [-16.13, 10.26] 
bSmoking -678.88 -.44 211.10   .011 [-1208.45, -199.70] 
Regression Model        R = .58        Adjusted R2 = .19        F (6, 29) = 2.39, p = .053 
Note. N = 36. CI = confidence interval; bBDI-II = baseline Beck Depression Inventory-II; IT = 
interval training; CTHi = constant training high intensity; bFEV1 % = baseline forced expiratory 
volume in the first second percent of predicted normal value; bSmoking = smoking at baseline. 
aBootstrap results are based on 1000 bootstrap samples. bConfidence intervals are bias-corrected 
and accelerated. 
 
The analysis was repeated with the multivariate outlier removed (see Table 6 
below). The full model then accounted for 46 % (adjusted R2) of the variation of exercise 
levels at follow-up. Within the context of this model, baseline BDI-II emerged as the 
strongest independent predictor of exercise levels at follow-up. Baseline Smoking was the 
only significant covariate to emerge and predicted lower exercise levels at follow-up. 
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These results, derived from data with the multivariate outlier excluded, are less biased and 
more representative of this sample (see Appendix C, Tables 29 and 30). 
 
Table 6 
Multiple Regression Model for Prediction of Exercise Levels at Follow-Up by Baseline 
BDI-II with Covariates (Multivariate Outlier Removed) 
  Bootstrapa 
Variable   B         ß        SE B    p 95 % CI for Bb 
Constant 1923.64  527.47   .004 [1033.71, 3005.76] 
bBDI-II    -62.06      -.50 18.67   .004 [-106.02, -30.55] 
IT     41.85 .03 267.19   .882 [-438.50, 557.68] 
CTHi     41.88 .03 244.09   .868 [-471.41, 539.28] 
Sex (F) -188.55 -.14 210.40   .351 [-603.64, 113.50] 
bFEV1 %     -4.15 -.11 6.13   .487 [-18.55, 8.23] 
bSmoking -557.23 -.41 174.16   .008 [-899.97, -118.53] 
Regression Model        R = .75        Adjusted R2 = .46        F (6, 28) = 5.84, p < .001 
Note. N = 35. CI = confidence interval; bBDI-II = baseline Beck Depression Inventory-II; IT = 
interval training; CTHi = constant training high intensity; bFEV1 %  = baseline forced expiratory 
volume in the first second percent of predicted normal value; bSmoking = smoking at baseline. 
aBootstrap results are based on 1000 bootstrap samples. bConfidence intervals are bias-corrected 
and accelerated. 
 
A moderation model was tested, again using the method by Hayes (2013), to 
determine if the relationship between baseline BDI-II (the predictor) and exercise levels 
at follow-up (the outcome) changed as a function of sex (the moderator) while adjusting 
for baseline exercise intervention, FEV1 % predicted, and smoking status. A significant 
interaction effect was found between baseline BDI-II and Sex (b = 116.22, 95 % CI [22.33, 
209.96], t = 2.54, p = .017), indicating that the relationship between baseline BDI-II scores 
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and MET minutes of exercise at 9 months post-PR was indeed moderated by the sex of 
the participants (see Figure 9). With female participants, there was a non-significant 
negative relationship between baseline depression symptomatology and follow-up 
exercise levels, b = -29.30, 95 % CI [-66.05, 7.44], t = -1.64, p = .113. However, with 
male participants, there was a stronger and statistically significant negative relationship 
between baseline depression symptomatology and follow-up exercise levels, b = -145.45, 
95 % CI [-235.45, -55.45], t = -3.32, p = .003. (This occurred despite the lower variability 
of male BDI scores compared to that of females, thus confirming that the moderation was 
indeed due to sex, not the differences in variability of BDI scores). 
 
 
Figure 9. Baseline depression predicting exercise levels at follow-up  
moderated by sex (adjusting for PR exercise intervention, baseline FEV1%  
predicted, and smoking status; multivariate outlier removed, N = 35. 
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Mediation models were also tested and no variables were found to mediate the 
relationship between baseline BDI-II and PR attendance, PR exercise compliance, or 
levels of exercise maintained at follow-up. 
 
Secondary Multivariate Analyses 
Secondary analyses, exploratory in nature, were run with the objective of developing 
linear regression models with the fewest IVs that could best predict each outcome: PR 
attendance, PR exercise compliance, and exercise levels at follow-up. Predictors were 
selected based on their Pearson correlations with each outcome (see Appendix B, Table 
39), their emergence as significant covariates in the primary analyses, findings of previous 
studies, and theory. It was decided a priori that the ratio of predictors to number of 
participantsts would be no larger than 1/6 due to the relatively small N of our sample. For 
all analyses, the univariate BDI-II extreme outlier was winsorized to reduce bias (see 
Appendix C Tables 31 to 37 for assessments of bias and normality justifying winsorizing 
the high BDI-II score). Bootstrapping (using 1000 samples) was again performed because 
of the relatively small sample size and violation of some assumptions for linear regression. 
 
A standard linear regression with PR attendance as the outcome and baseline 
FEV1% predicted, cohabiting (or not), and HLC Other People scale, as predictor variables 
was found to account for 36% (adjusted R2) of the variation in PR attendance, which 
predicted the outcome significantly better than using its mean. As can be seen in Table 7, 
higher FEV1% and cohabiting were significant predictors of higher PR attendance. HLC 
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“Other People” strengthened the model somewhat, though it did not reach statistical 
significance. 
 
Table 7 
Multiple Regression Model with Strongest Predictors of PR Attendance 
  Bootstrapa 
Variable       B         ß        SE B     p 95 % CI for Bb 
Constant -9.20  23.55    .716 [-52.59, 42.05] 
bFEV1 % 0.92 .57   0.26    .004 [0.43, 1.34] 
Cohabiting 24.04 .42   9.44    .026 [5.78, 43.21] 
HLC other 
people 4.27 .22   2.83    .144 [-1.02, 9.95] 
Regression Model        R = .65        Adjusted R2 = .36        F (3, 32) = 7.64, p = .001 
Note. N = 36. CI = confidence interval; FEV1 % = forced expiratory volume in the first second 
percent of predicted normal value; HLC = health locus of control scale. 
aBootstrap results are based on 1000 bootstrap samples. bConfidence intervals are bias-corrected 
and accelerated. 
 
 
Next, it was found that a multiple regression model comprised of the IT and CTHi 
exercise protocols (CTVT as the reference), sex, FEV1 % predicted, and baseline BDI-II 
accounted for 47 % (adjusted R2) of the variation in PR exercise compliance. Each 
predictor’s contribution, except for CTHi, was statistically significant. The IT exercise 
intervention, higher baseline BDI-II scores, and higher baseline FEV1 % were predictive 
of lower PR exercise compliance, while being female predicted higher exercise 
compliance (see table 8 below). 
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Table 8 
Multiple Regression Model with Strongest Predictors of PR Exercise Compliance 
  Bootstrapa 
Variable     B       ß        SE B p 95 % CI for Bb 
Constant 141.85  19.31 .001 [100.75, 181.61] 
BDI-II -2.48 -.40   0.97 .031 [-4.41, -0.58] 
IT -54.49 -.77 11.23 .003 [-76.87, -28.48] 
CTHi -10.10 -.14  9.72 .322 [-28.18, 5.89] 
Sex (F) 26.75  .38 11.00 .027 [3.40, 47.94] 
FEV1 %  -0.57 -.33   0.28 .029 [-1.10, -0.09] 
Regression Model        R = .74        Adjusted R2 = .47        F (5, 30) = 7.32, p < .001 
Note. N = 36. CI = confidence interval; BDI-II = Beck Depression Inventory-II; IT = interval 
training; CTHi = constant training high intensity; FEV1 % = forced expiratory volume in the first 
second, percent of predicted normal value. 
aBootstrap results are based on 1000 bootstrap samples. bConfidence intervals are bias-corrected 
and accelerated. 
 
 
Next, a multiple regression analysis was run on the outcome of exercise levels at 
follow-up with baseline BDI-II, smoking status, and health locus of control (HLC) chance 
scale as predictors. Examination of residuals revealed an extreme multivariate outlier 
(standardized residual = 3.79), which exerted substantial influence on the model as a 
whole (see Appendix C, Tables 34 to 37). Regression results are therefore presented for 
analyses that included the outlier followed by those for which the outlier was removed, as 
suggested by Field (2013) and Tabachnick and Fidell (2013). Table 9 below presents 
results, which included the outlier. The model predicted the outcome significantly better 
than the outcome’s mean accounting for 33 % (adjusted R2) of the variation in exercise 
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levels at follow-up. Baseline smoking status and higher HLC Chance scores were 
statistically significant predictors of lower levels of exercise at follow-up. Baseline BDI-
II’s contribution was weak and not statistically significant.  
 
Table 9 
Multiple Regression Model with Strongest Predictors of Exercise Levels 
 at Follow-Up (Multivariate Outlier Included) 
  Bootstrapa 
Variable   B        ß        SE B p 95 % CI for Bb 
Constant 2178.21       361.40 .001 [1216.11, 2830.27] 
BDI-II -23.95 -.18   31.69 .542 [-73.21, 29.93] 
bSmoking -800.41 -.52 197.14 .006 [-1262.08, -386.56] 
HLC chance -292.28 -.35   95.25 .009 [-503.91, -73.36] 
Regression Model        R = .65        Adjusted R2 = .37        F (3, 32) = 7.71, p = .001 
Note. N = 36. CI = confidence interval; BDI-II = Beck Depression Inventory-II; bSmoking = 
smoking at baseline; HLC = health locus of control. 
aBootstrap results are based on 1000 bootstrap samples. bConfidence intervals are bias-corrected 
and accelerated. 
 
 
 
However, this changed markedly when the multivariate outlier was removed. Table 10 
presents results from the analysis with the multivariate outlier removed (n = 35). 
(Removing the multivariate outlier reduced bias and improved the generalizability of the 
model, but bootstrapping was still used because of heterogeneity of variance, see Table 
37 in Appendix C). The regression model was significantly better at predicting post-PR 
exercise levels than using its mean. The three predictors combined accounted for 62 % 
(adjusted R2) of the variation in exercise levels 9-months post-PR. Higher baseline BDI, 
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smoking at baseline, and lower HLC Chance all emerged as statistically significant 
independent predictors of lower exercise levels at follow-up. 
 
 
Table 10 
Multiple Regression Model with Strongest Predictors of Exercise Levels 
 at Follow-Up (Multivariate Outlier Removed) 
  Bootstrapa 
Variable   B        ß       SE B  p 95 % CI for Bb 
Constant 2249.03       295.11 .001 [1608.14, 2845.93] 
BDI-II -56.33 -.45   14.02 .002 [-86.73, -31.24] 
bSmoking -643.34 -.48 131.78 .001 [-923.54, -374.90] 
HLC chance -273.16 -.38   79.22 .002 [-427.81, -106.10] 
Regression Model        R = .81        Adjusted R2 = .62        F (3, 31) = 19.38, p < .001 
Note. N = 35. CI = confidence interval; BDI-II = Beck Depression Inventory-II; bSmoking = 
smoking at baseline; HLC = health locus of control. 
aBootstrap results are based on 1000 bootstrap samples. bConfidence intervals are bias-corrected 
and accelerated. 
 
 
 
Differences Between Study Completers and Dropouts 
Differences in baseline characteristics, PR attendance and PR exercise compliance 
levels between participants who attended the follow-up evaluations (completers) and those 
who did not (dropouts) were examined. Boxplots and Mann-Whitney U tests were used 
for continuous variables, while bar graphs and Pearson chi-square tests were used for 
categorical data. Twenty-eight (78 % of the total) participants attended the follow-up 
evaluation 9 months post-PR, while eight (22 %, all females) did not. Mann-Whitney U 
tests (see Table 11) revealed that dropouts (participants who did not attend follow-up  
 71 
Table 11 
Differences Between Study Completers and Dropouts Assessed with Mann-Whitney U 
Baseline 
Characteristics 
& PR Data 
Median for 
Completers 
(n = 28) 
Median for 
Dropouts 
(n = 8) 
 
U 
Statistic 
z 
(Stand. Test 
Statistic) 
P a 
(2-tailed) 
 
Effect 
Sizeb 
Age 69.0 64.0 86.0 0.99 .333 .16 
BMI 27.3 25.2 92.0 0.76 .466 .13 
Smk Hx p-yrs 42.5 37.5 93.5 0.71 .492 .12 
HLC internal   4.7   4.0 83.5 1.09 .287 .18 
HLC chance   2.5   2.8 106.0 0.23 .830 .04 
HLC doctor   5.5   5.0 89.0 0.91 .374 .15 
HLC other 
people 
 
  3.0 
 
  2.8 
 
87.5 
 
0.94 
 
.361 
 
.16 
BDI-II   7.0   11.5 56.5 2.12 .033 .35 
FEV1 % 64.9   44.9 54.0 2.21 .027 .37 
FEV1/FVC % 52.1   42.2 45.0 2.55 .009 .42 
ESWT 
seconds     380.5 281.5 65.5 1.77 .078 .29 
PR Attend % 87.5   52.8 55.0 2.18 .028 .36 
PR Exercise 
Compliance % 
 
96.7 
 
 71.3 
 
59.0 
 
2.02 
 
.043 
 
.34 
Note. BMI = body mass index, Smk Hx p-yrs = smoking history in pack-years, HLC = Health 
Locus of Control scale (0-6), BDI-II = Beck Depression Inventory (0-63), FEV1 % = forced 
expiratory volume in 1 second percent of predicted normal value, FEV1/FVC = ration of forced 
expiratory volume in one second to forced vital capacity, ESWT = endurance shuttle walking 
test, PR Attend % = percent of pulmonary rehabilitation classes attended, PR Exercise 
Compliance % = percent of total pulmonary rehabilitation exercise session time during which 
participant was exercising within or above their target heart rate range.  
aThe exact method was used to calculate p.  
bThe effect size was calculated by dividing z (standardized test statistic) by the square root of N 
(Field, 2013). 
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evaluations) had statistically significant higher baseline depression scores, lower FEV1 % 
predicted and FEV1/FVC values, and lower rates of both PR attendance and PR exercise 
compliance. 
 
Bar graphs illustrate differences in baseline nominal variables between study 
completers and dropouts (see Figure 10 below). Pearson’s chi-square tests of 
independence were also conducted to determine whether sex, smoking status, cohabiting 
status (living alone vs. with someone), or the prescribed exercise training regimen for PR 
were each associated with completing the study or dropping out. There was a significant 
association between sex and attendance at the follow-up evaluations: 2 (1) = 5.81, p 
(Fisher’s exact sig.) = .032: Females tended to drop out whereas males tended to complete 
the follow-up evaluation. The association between baseline smoking status and 
completing the study was not statistically significant: 2 (1) = 3.94, p (Fisher’s exact sig.) 
= .086. However, there was a trend of participants smoking at baseline being more likely 
to drop out. There was virtually no association between cohabiting status and attendance 
at follow-up evaluation: 2 (1) = .080, p (Fisher’s exact sig.) = 1.000. The association 
between PR exercise intervention and follow-up attendance was significant: 2 (2) = 9.0, 
p (Fisher’s exact sig.) = .014, Cramer’s V = .500, p (exact significance) = .014. 
Participants undergoing IT exercise during PR had the highest drop-out rate with 75 % 
not attending follow-up, followed by 25 % dropout rate for CTHi, and 0 % for CTVT. 
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Figure 10. Differences between study completers (did attend follow-up evaluation,  
n = 28) and dropouts (did not attend, n = 8).   
 
 
 
 
 
 
  
Discussion 
  
Primary Findings 
This study investigated baseline depressive symptoms as a predictor of: 1) 
attendance at PR exercise sessions, 2) compliance with endurance exercise intensity 
targets prescribed for PR, and 3) level of exercise maintained 9-months post-PR in a 
sample of patients with moderate to severe COPD. After adjusting for covariates, we 
found that while greater baseline depressive symptomatology did not predict PR 
attendance, it did predict lower compliance with exercise targets during PR as well as 
lower levels of exercise maintained at 9-months post-PR. This indicates that depressive 
symptoms at entry to PR may be more predictive of exercise compliance than attendance 
during PR, and predict the maintenance of physical exercise after termination of PR.  
 
Depressive Symptoms 
Depression symptomatology at baseline (entry to PR) was generally low in our 
sample (median = 8.5, IQR = 6-13), with only 14 % of participants having symptoms at 
or above the “caseness” threshold, as measured by the BDI-II. This is lower than levels 
generally reported in the COPD population (K. M. Hynninen et al., 2005; Mikkelsen et 
al., 2004) and may be due to self-selection for participating in this intervention study; 
patients who consented to undergo the 36 exercise sessions over 12 weeks may have had 
less depression than those who declined, as has been documented for patient uptake in PR 
following initial assessment (Cassidy et al., 2014; Johnston & Grimmer-Somers, 2010).
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Depression and PR Exercise Session Attendance 
PR attendance levels, defined as the percentage of total number of sessions attended,  
were generally high (median = 84 %, IQR = 67-94), a rate similar to those found in a 
review of RCTs on PR (Bjoernshave, Korsgaard, & Nielsen, 2010). Contrary to our 
hypothesis, baseline depressive symptoms did not predict PR attendance in our sample, in 
both univariate and multivariate analyses. This may have been due to the generally low 
levels of depressive symptoms, which may not have interfered with attendance. 
Furthermore, the close supervision, attention, and support afforded by the high ratio of 
two supervisors (trained exercise physiologists) per six participants may have helped 
overcome the potential impact of depressive symptoms on attendance.  
 
Our finding conflicts with many previous studies which found an association 
between baseline depressive symptoms and PR attendance; however, this discrepancy 
may be due to different participant characteristics, larger sample sizes, and the timing of 
attendance measures. For example, Fan et al. (2008) in the National Emphysema 
Treatment Trial (NETT), who observed similar mean baseline depression scores on the 
original version of the BDI, found that greater baseline depressive symptomatology did 
predict lower attendance at PR exercise sessions. However, they measured attendance at 
10 PR exercise sessions delivered over a 9 to10-week period that followed an initial 16 to 
20 mandatory exercise sessions that were performed over a 6 to 10-week period prior to 
randomization. It was only during the post-randomization phase consisting of 10 exercise 
sessions that an association between baseline depression symptoms and attendance was 
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measured and found. It has been documented that attendance diminishes as the length of 
a PR program increases (Sabit et al., 2008), which may be why an association between 
baseline depression levels and attendance was found in the NETT study but not in ours: 
our study measured attendance from week 0 to 12 of PR, whereas attendance was 
measured starting sometime between the 7th to the 11th week of exercise and ending 
sometime between the 16th and 19th week in the NETT trial. Another possible explanation 
for the discrepancy in findings between our study and the NETT is that patients’ COPD 
was much more severe in the NETT (mean FEV1 % = 27, SD = 7) compared to our sample 
(mean FEV1 % = 59, SD = 17). COPD severity might have moderated the relationship 
between depressive symptoms and attendance such that an association might only have 
emerged in the context of more severe COPD than was present in our sample. Of note, a 
moderation model was tested in our study, but no interaction was found between baseline 
depressive symptoms and FEV1 % predicted (as a measure of COPD severity). 
 
Our results are also inconsistent with those of Garrod et al. (2006), who also found 
that depression predicted attendance at PR exercise sessions. Patients who completed < 
10 out of 14 PR sessions were defined as dropouts. The authors stratified baseline and 
outcome measures according to Medical Research Council dyspnea grades and reported 
that 46 % of dropouts had a Medical Research Council dyspnea grade of 5 or “severe.” 
Unfortunately, the authors presented no scores for depression despite listing it as one of 
their primary outcomes and reporting that it independently discriminated PR completers 
from PR drop-outs. Once again, it is possible that the association between depression and 
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attendance found in that study emerged in the context of greater COPD severity than was 
present in our study, and that this could account for the discrepant findings.  
 
Yet another study reporting that baseline depression levels predicted PR attendance 
was conducted by Hogg et al. (2012). They reported higher levels of baseline depression 
in their sample relative to ours (31 % at or above the “caseness” threshold, as measured 
by the Hospital Anxiety and Depression Scale, versus 14 % in ours, as measured by the 
BDI-II). Furthermore, their sample was comprised of a larger proportion of patients whose 
COPD was more severe: 52 % with GOLD stages III & IV versus only 37 % in our sample. 
The higher levels of baseline depression and more severe COPD within a much larger 
sample (n = 656) than ours may have resulted in the emergence of depression as a 
statistically significant independent predictor of PR attendance in their analysis. Greater 
severity in both COPD and depression, and larger sample sizes, may explain why an 
association between baseline depression and PR attendance emerged in these studies but 
not in ours.  
 
Depression and PR Exercise Compliance 
To our knowledge, this was the first study to examine baseline depressive 
symptomatology as a predictor of compliance with the aerobic exercise intensity 
prescribed in PR. Previous “adherence” studies have only reported levels of PR uptake 
and attendance. We used continuous data tracking technology that measured heart rate 
during each and every exercise training session to determine the percentage of time 
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participants were exercising within or above their target heart rate range. Levels of 
compliance were high overall: the median proportion of time that participants exercised 
within or above the target heart rate zone was 94 % (IQR = 71-99 %). Univariate 
correlational analyses revealed a negative association between baseline depressive 
symptomatology and compliance with prescribed exercise intensity. Multivariate analyses 
also found that greater depressive symptomatology predicted lower compliance (ß = -.40), 
after adjusting for exercise protocol, sex, baseline FEV1 % and smoking status. Finding 
this significant relationship in the context of generally low levels of depressive symptoms, 
high levels of compliance, and a relatively small sample size, suggests that baseline 
depressive symptoms may be a fairly robust predictor of exercise compliance. This finding 
is similar to those of related studies which have investigated the impact of depression on 
compliance with a variety of health behaviors (other than exercising at specified 
intensities) prescribed across a range of medical conditions (DiMatteo et al., 2000; 
Grenard et al., 2011).  
 
To our knowledge, only one other study (Lavoie et al., 2004) has ever investigated 
the association between depressive symptoms and compliance with a target exercise 
intensity, but this was with a sample of patients with coronary artery disease as opposed 
to COPD. Lavoie et al. investigated this association in the context of an exercise stress 
test, and assessed performance of patients undergoing electrocardiography or single-
photon-emission-computer-tomography for the detection of myocardial ischemia. 
Baseline depressive symptoms were measured with an earlier version of the Beck 
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Depression Inventory (BDI) and the Primary Care Evaluation of Mental Disorders 
(PRIME-MD). They measured exercise stress test performance using total exercise METs, 
duration, and, as in our study, they recorded the percent of maximum predicted heart rate 
as an indicator of exercise intensity. Consistent with our findings, they reported a 
significant negative association between meeting criteria for a baseline depression (both 
major depressive disorder and subthreshold symptom levels) and their three measures of 
exercise performance. Patients with higher levels of depression performed more poorly 
on their exercise stress tests to the extent that some were unable to achieve the minimum 
level of intensity required for a valid stress test outcome in detecting myocardial ischemia 
(which increased the risk for false negative tests).  
 
Our findings also correspond to the manifestation and impact of depressive 
symptoms in daily life: both cognitive and somatic symptoms of depression can make 
initiating and sustaining even moderate levels of exercise (and other health behaviors) too 
difficult to engage in (Detweiler-Bedell, Friedman, Leventhal, Miller, & Leventhal, 2008; 
Roshanaei-Moghaddam et al., 2009). For example, a lack of pleasure, interest and 
motivation; feeling hopeless; difficulty concentrating, possibly combined with insomnia, 
fatigue, and psychomotor retardation are all potential obstacles to reaching exercise 
targets, even when patients do attend PR sessions. 
 
Exercise protocol as a moderator. We found a significant interaction between 
baseline BDI-II score and type of endurance exercise (i.e., CTVT, CTHi, and IT), 
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indicating that exercise protocol moderated the relationship between baseline depressive 
symptomatology and exercise compliance during the PR program. The strength of the 
inverse relationship between baseline depressive symptomatology and exercise 
compliance was greatest for the IT exercise protocol, followed by CTVT, and weakest for 
CTHi. Physiological and respiratory response measures taken during exercise, previously 
reported by Rizk (2014), indicate that IT was the most demanding in terms of metabolic 
strain (followed by CTHi and CTVT) and was therefore the most difficult for our 
participants to comply with. The moderation model suggests that the negative impact of 
baseline depressive symptomatology on exercise compliance increased with the demands 
of the exercise protocol, a finding supported by some previous studies, though not in the 
context of COPD (Callaghan, Khalil, Morres, & Carter, 2011; Khalil, Callaghan, Carter, 
& Morres, 2012; Morgan, 2001). It is interesting that in the moderation model, baseline 
depressive symptomatology had a greater (negative) impact on CTVT compliance than on 
CTHi because CTVT was of a lower intensity (i.e., easier for participants) than CTHi. 
One possible explanation is that CTVT’s duration was on average 5 minutes and 40 
seconds longer than CTHi’s and that the association between baseline depression and 
compliance may have been driven by the longer duration of CTVT rather than the 
difference in exercise intensity between CTVT and CTHi: the difference between CTVT 
and CTHi target exercise intensity was relatively small (on average 7.6 heart beats per 
minute) compared to the difference between CTHi and IT (16.1 heart beats per minute). 
A second possible explanation, presented by Rizk et al. (2015) is that the greatest drop in 
global positive affect (the degree of pleasure experienced) occurred in participants 
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undergoing the CTVT exercise regimen halfway through their exercise session. This 
suggests that they may have experienced a state of boredom due to under arousal, 
compared to participants in the CTHi and IT interventions (Rizk, 2014). To summarize, 
baseline depressive symptomatology may have had a greater negative impact on 
compliance within the CTVT than on the CTHi group because of CTVT’s longer duration 
and the lower levels of arousal it produced. It has been reported that better exercise 
participation is achieved when participants with depression choose their own levels of 
exercise intensity (Callaghan et al., 2011); this may also apply in PR for COPD.  
 
Depression and Post-PR Exercise Levels 
In contrast to the overall high rates of PR attendance and exercise compliance, the 
median volume of exercise that participants reported engaging in at 9-months post PR was 
fairly low (706 MET minutes) when compared to the level recommended (842 MET 
minutes), which was based on the amount of exercise performed during participants’ final 
three PR sessions. In fact, 58 % of participants fell short of meeting their prescribed 
weekly target, a finding consistent with previous reports on post-PR levels of exercise and 
physical activity (Cindy Ng et al., 2012; Soicher et al., 2012). 
 
In support of our hypothesis, greater baseline depressive symptomatology predicted 
lower levels of exercise maintained at follow-up in both univariate and multivariate 
analyses (ß = -.50), again adjusting for exercise protocol, sex, baseline FEV1 % and 
smoking status. This is consistent with the findings of Heerema-Poelman et al. (2013) and 
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Roshanaei-Moghaddam et al. (2009), who also found that higher depressive 
symptomatology was associated with a longitudinal decline in the levels of exercise 
maintained. Of note in our study is that baseline depression, compared to all other 
variables, emerged as the strongest predictor of post-PR exercise behavior in the context 
of our covariates. It is not surprising that after termination of the PR program, with the 
loss of the support, guidance, assurances, and structure it provided, that many participants 
did not autonomously maintain the levels of exercise they were engaging in during the 
program, especially those who had higher levels of depressive symptoms at the start of 
PR.  
 
Interestingly one remarkable exception to this pattern emerged (a multivariate 
outlier) who had the second highest baseline BDI-II score and yet reported engaging in 
the highest level of exercise post-PR. This single case represents the ideal PR outcome for 
a patient with COPD and comorbid depressive symptoms. Closer examination revealed 
that this 65-year old female with moderate COPD had a history of regular walking for 
exercise, had quit smoking 3 months before starting PR, had hypothyroidism (with 
symptoms of fatigue, dizziness, hot flashes indicating a possible hormone imbalance 
during the period of PR), and was experiencing some stress related to her elderly parent’s 
and her own living arrangements. Post-PR, she had resumed walking 5 days per week, 
remained a non-smoker, had settled her living arrangements, and had received an 
increased dose of thyroid medication. Her post-PR BDI score was 6, down from her 
baseline of 21. It is not known whether she received treatment for her depressive 
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symptoms per se, however it is well known that inadequately treated hypothyroidism can 
manifest with symptoms similar to depression. This case illustrates how adequate 
treatment may help alleviate the negative impact that clinically significant depressive 
symptoms can have on PR outcomes. 
 
Sex as a moderator. We determined that sex moderated the relationship between 
baseline depressive symptomatology and exercise levels maintained 9 months after PR: 
the negative association between baseline depressive symptoms and post-PR exercise 
levels was significantly stronger for men than for women. This suggests that the women 
in our sample were less impacted by the presence of baseline depressive symptoms than 
the men with regards to continuing to exercise after PR. This finding emerged despite a 
trend of higher baseline depressive symptoms in women (mean = 10, SD = 5.8) compared 
to men (mean = 7, SD = 4.4) in our sample, which is consistent with the higher rates of 
depression (subclinical and clinical) reported in women in the general adult population 
(Nolen-Hoeksema, 2001; Weissman et al., 1996). This might be explained by some of the 
gender differences in the way depression is experienced, responded to, reported, and 
impacts daily functioning. For example, one study (Poutanen, Koivisto, Mattila, 
Joukamaa, & Salokangas, 2009) found that significantly more depressed men than women 
reported that “everything was an effort,” which may result in poorer maintenance of 
regular exercise, which requires some (physical) effort. Another possible explanation is 
that perhaps many women in our sample were, as homemakers, more accustomed to 
engaging regularly in physical activity at home over the years than men, whose physical 
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activity was linked more to their work outside the home, and who became more sedentary 
after retiring (Nolen-Hoeksema, 1990). This, however, is only speculative: the literature 
on sex differences in depression is vast, complex, and inconclusive and we cannot provide 
any definitive explanation for sex moderating the relationship between baseline depressive 
symptoms and exercise levels post-PR, though it might merit further investigation. 
 
In summary, finding a negative association between baseline depressive 
symptomatology and exercise intensity compliance, but not attendance in this sample, 
suggests that baseline depressive symptomatology may have had a greater impact on these 
patients’ ability to achieve and sustain target exercise intensities than it did on attending 
PR sessions. However, given that patients had to volunteer to participate in the study, it is 
likely there was some degree of selection bias, with patients with severe depression being 
less likely to volunteer for a demanding PR trial such as this. Further, for those who did 
participate in the study, once the structure and support of supervised PR ended, baseline 
depression appeared to exert its greatest impact on levels of exercise maintained 
autonomously (an example of a substantial behavior change challenge). 
 
Secondary Findings 
Our secondary objectives were exploratory and conducted in order to generate 
hypotheses to be tested in future research. One objective was to identify baseline variables, 
in addition to depressive symptomatology, that were predictive of outcomes in our sample. 
These emerged as significant variables in correlational analyses or as significant 
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covariates in our primary regression analyses. Using these baseline variables, we derived 
three separate regression models composed of the fewest number of variables that 
accounted for the greatest variance in each of our three outcomes. Our hypothesis was 
supported: The sets of baseline variables that predicted PR attendance, PR exercise 
compliance, and level of exercise maintained post PR were different for each outcome. 
Findings must be interpreted with caution due to the limited sample size and study design: 
they only signal possible relationships and, as such, suggest topics for further research.  
 
Strongest Predictors of PR Attendance  
In bivariate analyses, baseline FEV1 % predicted had a positive and significant 
correlation with PR attendance. In multivariate analyses, independent predictors of higher 
PR attendance were: higher FEV1% (ß = .57), cohabiting (ß = .42), and stronger “other 
people” health locus of control orientation (ß = .22), with the latter not reaching statistical 
significance but contributing nevertheless to the regression model, which overall 
accounted for 36 % of the attendance variance (see Table 7). FEV1 % predicted is a 
measure of COPD severity and the positive association with PR attendance found in this 
study is consistent with previous reports from studies with much larger sample sizes (Fan 
et al., 2008; Hayton et al., 2013). Though a causal relationship cannot be drawn from the 
present (or previous) studies, it is likely that participants with more severe COPD (poorer 
lung function) experience greater symptoms of dyspnea and fatigue, more frequent COPD 
exacerbations (O'Donnell et al., 2007), and may therefore attend fewer PR sessions than 
those whose disease is less severe. Living alone also emerged as a significant independent 
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predictor or lower PR attendance, a finding consistent with those reported in the review 
by Keating et al. (2011). This association may be due to the fact that participants who live 
by themselves bear more or all of the responsibility for tasks of daily living (such as 
shopping and other errands, preparing meals, maintaining their home, travel and 
transportation), which may sometimes not leave them adequate time and energy needed 
to attend PR sessions. Another possibility is that people living alone may not receive as 
much support or encouragement for attending an exercise program, which has been linked 
to poorer attendance or dropout (Hayton et al., 2013; Keating et al., 2011). Having a 
stronger other people health locus of control orientation was a third independent predictor 
of greater attendance. It refers to a belief that other people play a role in or can impact 
one’s own health. Although an other people locus of control as a predictor of PR 
attendance did not reach statistical significance, we retained it because, to our knowledge, 
this is the first study to investigate health locus of control in COPD and it did contribute 
somewhat to the regression model. In contrast to participants with an internal HLC 
orientation, those with a more external other people health locus may respond more 
favorably to sources of motivation outside themselves, such as the support of trainers and 
interactions/discussion with a group of peers (integral to PR), resulting in higher 
attendance. Normally, an external locus of control orientation was believed to be 
associated with poor engagement in health-related behaviors (Norman, Bennett, Smith, & 
Murphy, 1998). However, our finding along with those others (Burk & Kimiecik, 1994; 
Janowski, Kurpas, Kusz, Mroczek, & Jedynak, 2013) suggest that an other people 
orientation may be linked to greater engagement in certain health behaviors, depending 
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perhaps on the specific context, such as learning and adopting new health management 
behaviors in a group rehabilitation setting. Although inconclusive here, locus of control 
may merit further investigation to determine if it helps drive PR attendance. 
 
Strongest Predictors of PR Exercise Compliance 
Correlational analyses indicated significant and borderline significant associations 
respectively between both the IT exercise protocol, baseline BDI-II, and PR exercise 
compliance. In multivariate analyses, IT (ß = -.68), higher baseline BDI-II (ß = -.41), male 
sex (ß = -.35), and higher FEV1 % pred (ß = .30) were the strongest predictors of lower 
PR exercise compliance and together accounted for 48 % of its variance. All four variables 
were significant independent predictors. Surprisingly, IT was associated the lowest levels 
of exercise compliance (median of 49 %), compared to the CTVT and CTHi (medians of 
98 % and 95 %, respectively), and emerged as the strongest independent predictor of poor 
exercise compliance. Physiological and respiratory measures (i.e., heart rate, respiratory 
rate, minute ventilation) previously reported by (Rizk, 2014) indicated that IT was the 
most demanding exercise regimen, compared to CTHi and CTVT. This is contrary to 
previous reports where IT was recommended and offered as an exercise option because it 
was better tolerated by patients with more severe COPD (Sabapathy, Kingsley, Schneider, 
Adams, & Morris, 2004; Vogiatzis et al., 2004). As explained by Rizk et al. (2015), the 
disparity between our finding and that of Sabapathy et al. (2004) can be attributed to our 
IT intervals being shorter (30 versus 60 seconds), higher in relative intensity (100 % versus 
70 % peak wattage), and our recovery being an active one (unloaded pedaling intervals) 
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versus complete rest. These factors may not have allowed for sufficient rest to repeatedly 
attain the target heart rate that was prescribed for the exercise interval. Other findings, 
such as those of Vogiatzis et al. (2004), conflict with ours possibly because their 
continuous training protocol was of higher intensity than our CTHi, which resulted in their 
IT being relatively easier and better tolerated compared to IT (see Rizk et al., 2015). 
Furthermore, IT, which required repeatedly alternating between recovery and maximal 
intensity every 30 seconds throughout the whole training duration, may have demanded 
levels of alertness and motivation which surpassed those of many participants, especially 
those with higher baseline depressive symptomatology.  
 
As with the primary multivariate analyses, higher baseline depressive 
symptomatology (BDI-II score) remained a significant independent predictor of lower 
exercise compliance (ß = -.41) in our exploratory analysis. Again, depressive symptoms 
may limit participants’ capacity to achieve and sustain target intensities prescribed for PR. 
Female sex was a significant independent predictor of greater endurance exercise 
compliance. This suggests that women with COPD may better tolerate endurance exercise 
than men and therefore sustain their target intensity during training, but this hypothesis 
remains speculative. It is possible that the women in our sample were more accustomed 
than the men to meeting the physical demands of daily activities and continuing to 
function despite fatigue, physical discomfort, and even symptoms of depression; 40 years 
ago women were traditionally the primary caretakers of their children (Nolen-Hoeksema, 
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2002), and 42 % were also working outside the home in 1976 (Statistics Canada, 2015). 
This may have increased their tolerance for physical activity generally. 
 
Another unexpected finding was that lower FEV1 % was a significant independent 
predictor of greater PR exercise compliance in our sample. One would have thought that 
worse lung function (indicating more severe COPD) would be associated with poorer, not 
better, PR exercise compliance. We are not aware of any other studies that have 
specifically examined the association between baseline FEV1 % and exercise compliance 
with which to compare our findings. A possible explanation for this negative association 
is that the target exercise intensities for patients with more severe disease were lower than 
those of patients with better lung functions, such that healthier patients had to reach and 
sustain higher target exercise intensities throughout every one of their PR sessions. This 
may have proven to be more difficult. Secondly, it is possible that patients with more 
severe disease were more motivated to comply with their training targets than those with 
milder COPD if they believed in, or actually experienced, greater improvements in terms 
of functional capacity, dyspnea, fatigue, and quality of life from PR. This may have 
motivated them to reach their exercise targets when in attendance. In support of this 
hypothesis, several studies have found that milder COPD (greater FEV1 %) is linked to 
dropout among some patients because they do not feel they are benefitting from PR 
enough to continue (Fischer et al., 2009; Harrison et al., 2012; Hayton et al., 2013). 
Similarly, Di Meo et al. (2008) found, in a sample of older patients, that those with worse 
COPD achieved greater benefit (increase in their 6MWT distance) relative to their 
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baseline values than patients whose COPD was less severe. The authors, however, do not 
report on patients’ levels of attendance at or compliance to their exercise program during 
PR. In another study conducted by Spruit et al. (2015), patients were clustered into 
categories reflecting their responses to PR. The “very good responders” had poorer 
physical and mental health status and worse dyspnea at baseline. Interestingly, this 
negative association between FEV1 % and exercise compliance is in direct contrast to the 
positive one we found between FEV1 % and PR attendance. This clearly illustrates how 
PR attendance and compliance are differentially predicted – they appear to have different 
facilitators and barriers. 
 
Strongest Predictors of Post-PR Exercise Levels 
In correlational analyses, baseline smoking status, baseline BDI-II, and having a 
chance locus of control orientation for one’s health all had significant negative 
correlations with levels of exercise maintained at 9-months post PR. In multivariate 
analysis, baseline smoking (ß = -.48), higher baseline BDI-II scores (ß = -.45), and greater 
chance locus of control orientation for health (ß = -.38) all remained independent 
predictors of engaging is less exercise post-PR and accounted for 62 % of this outcome’s 
variance.  In our sample, even low levels of baseline depression represented an important 
impediment for long-term exercise maintenance. This is consistent with the findings of 
Heerema-Poelman et al. (2013) who reported that baseline depressive symptomatology 
was an independent predictor of poor attendance at a supervised maintenance program for 
exercise that followed a PR program. It is also consistent with the findings of eight 
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longitudinal studies reviewed by Roshanaei-Moghaddam et al. (2009) in which baseline 
depression was a significant risk factor for decline in physical activity levels.  
 
Baseline smoking also emerged as a robust independent predictor of lower levels of 
exercise maintained at follow-up in our study. It is possible that baseline smoking was 
indicative of continued smoking, which may have limited exercise capacity at follow-up. 
This is consistent with previous studies that have reported a negative association between 
current smoking and maintenance of health promoting behaviors, including exercise 
(Hansen, Johnsen, & Molsted, 2016; Trost et al., 2002).  
 
To our knowledge, our study was the first to examine HLC as a predictor of exercise 
levels maintained after PR in COPD.  We found that a higher chance locus of control 
orientation for health was a significant independent predictor of lower levels of exercise 
at follow-up. A chance locus of control for health indicates the belief that fate, luck, 
genetics, or other forces over which one has no control, are responsible for the state and 
evolution of one’s health.  It is plausible that people who think their health is a matter of 
chance do not believe that their actions would have much impact, and therefore, would 
not be very motivated to pursue regular exercise or other health enhancing behaviors. This 
has been documented in multiple studies on the impact of health locus of control in a range 
of health-related behaviors. Steptoe and Wardle (2001) found that the odds of engaging in 
all 10 health-related behaviors that they examined were reduced by 20-35 % for 
participants with high chance locus of control scores.  
 93 
Differences Between Study Completers and Dropouts 
Another secondary objective was to examine the differences between study 
completers (participants who attended the follow-up evaluations 9-months post PR) and 
dropouts (those who did not attend follow-up evaluations). Eight participants (22 %) 
dropped out. They had significantly higher levels of baseline depressive symptomatology 
than completers, more severe COPD (as reflected by significantly lower FEV1 % predicted 
values and FEV1/FVC ratios), significantly lower PR attendance and PR exercise 
compliance levels, were significantly more likely to be female, to have undergone the IT 
exercise intervention (as opposed to CTVT or CTHi) during PR, and were more likely to 
be smoking at baseline.  
 
Strengths and Limitations 
Several limitations of this study should be noted and the findings interpreted with 
them in mind. The sample size was fairly small and homogeneous: 1) all participants were 
recruited from a single hospital center clinic through which they had all been referred for 
PR, 2) patients with more severe COPD who could not achieve a ventilatory threshold on 
baseline exercise tests, or who desaturated while exercising, were excluded, 3) self-
selection for study participation may have biased our sample towards individuals who 
were less depressed and more motivated than those who refused. Therefore, one should 
be cautious about the extent to which the present findings can generalize to the larger and 
more varied COPD population. Another consideration is that the level of supervision and 
support provided to participants during PR in this study, as with many clinical trials, was 
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likely much greater than in most PR programs and probably resulted in higher attendance 
and compliance levels than those normally seen. All this may have resulted in the limited 
variance and skewed results in some of our data, which could limit the generalizability of 
findings. Another potential limitation was reliance on self-report measures for several 
independent variables (e.g., depressive symptomatology, health locus of control 
orientation) and for our outcome of exercise level at post-PR follow-up (based on a 7-day 
physical activity diary). Data based on self-reported may not be entirely valid and was not 
verified with more objective measures. However, the selected self-report measures have 
been used widely in the health literature and their sound psychometric properties are well 
established.  
 
Despite some limitations, this study also had a number of notable strengths. It was 
the first, to our knowledge, to investigate the role of baseline symptoms of depression in 
predicting both attendance and exercise compliance (a true measure of PR adherence) 
during exercise-based PR, and levels of exercise maintained post-PR. All three outcomes 
are essential for understanding the extent to which participants benefit (or not) from PR 
and the variables that can predict this. The use of several objective measures was another 
strength of this investigation: rigorous standardized procedures were used to measure 
respiratory functions, determine exercise capacity and exercise prescriptions, and measure 
compliance with prescribed exercise intensity. It was also the first study to explore the 
possible role of HLC in the context of PR for COPD. 
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Future Research 
Further research is needed to confirm our findings and to better understand the 
differential impact of baseline depression (both clinical and subclinical) on PR attendance, 
but especially on PR exercise compliance and ongoing exercise post PR, as knowledge is 
especially lacking in these last two areas. Each of these aspects is a distinct component 
essential to the success of PR and a better understanding of their determinants could result 
in better screening and intervention to optimize the health benefits of PR. In light of our 
findings, HLC merits further investigation as a potentially important variable for 
successful self-management of health in COPD. RCTs of adjunct treatments during PR 
that specifically target comorbid depression in COPD (and possibly HLC), are also needed 
to determine if improvements in depression result in better PR health outcomes via better 
PR attendance and exercise compliance, and improved maintenance of exercise 
afterwards.  
 
From a broader perspective, there is a need to develop theoretical models (such as 
the downward spiral of COPD presented above) to help elucidate the interplay of the 
physical, neurobiological, cognitive, affective, and behavioral aspects of COPD and 
depression to understand how depression develops (or worsens) in COPD. For example, 
episodes of dyspnea in COPD are often trigger a response of heightened anxiety even 
panic, which can quickly result in sustained anticipatory anxiety about many activities and 
situations. Is it possible that repeated episodes of dyspnea (accompanied by heightened 
anxiety or panic) over time precipitate abnormalities of the monoaminergic systems like 
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the hypothalamic-pituitary-adrenal axis, and could this be partly why levels of depression 
are disproportionately high in COPD? Until such theoretical models are proposed and 
tested, it will be difficult to fully understand comorbid depression in COPD and to develop 
sound interventions targeting specific factors to improve health outcomes.  
  
Conclusion
  
In conclusion, we found in our sample of 36 participants with moderate-to-severe 
COPD, that attendance and exercise compliance during supervised PR were generally 
high, while levels of autonomous exercise maintained post-PR were relatively low 
(compared to levels prescribed). Baseline depressive symptomatology did not predict PR 
attendance, but did predict compliance to prescribed exercise intensity during PR and 
levels of exercise maintained 9-months post PR (with adjustment for covariates). This 
indicates that baseline levels of depression may differentially impact each. To our 
knowledge, this is the first study to examine depressive symptomatology at entrance to 
PR as a predictor of exercise compliance during PR for COPD. Endurance exercise 
training is the cornerstone of PR for COPD and complying with the prescribed exercise 
targets is crucial for obtaining optimal benefits. If the presence of even subclinical 
depressive symptomatology (let alone clinical depression) is associated with 
noncompliance with exercise targets during PR and lower levels of exercise maintained 
after PR ends, then its diagnosis and treatment may be key for improving PR outcomes. 
Depression is especially relevant because it is highly prevalent in COPD. Our findings 
support our argument that while measuring PR attendance is necessary for reporting on 
PR exercise adherence, it is not sufficient: compliance to exercise targets must also be 
assessed and reported. 
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We found that the type of endurance exercise intervention (CTVT, CTHi, or IT) 
moderated the relationship between baseline depressive symptoms and exercise 
compliance. We also found that sex moderated the relationship between baseline 
depressive symptoms and level of exercise maintained at 9-months post PR.  
 
Exploratory analyses identified several variables in addition to baseline depressive 
symptomatology that were independent predictors of each outcome. Interestingly, 
different variables predicted PR attendance, PR exercise compliance, and post-PR 
exercise levels in multivariate analyses, demonstrating that optimally benefitting from 
exercise-based PR is associated with a number of patient and exercise program 
characteristics which need to be considered for attainment of optimal PR outcomes. A 
HLC “other people” orientation may be positively associated with increased PR 
attendance, possibly due to a greater response to guidance and support from others, while  
high “chance” HLC orientation at baseline may be a significant predictor of lower exercise 
levels maintained 9-months post PR in this study.  
 
Clinical recommendations 
In light of these findings, we suggest that the assessment of both subclinical and 
clinical depression be incorporated into standard intake for PR and that treatment of 
depression be provided during (and if necessary following) PR programs as an essential 
component for helping patients with COPD obtain (and maintain) optimal benefits from 
PR. When both attendance and PR exercise compliance are measured, a composite 
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measure of PR exercise adherence can be calculated (i.e., percent attendance multiplied 
by percent exercise compliance) that can provide a comprehensive score of overall 
exercise adherence during PR. This could be useful for flagging participants during or at 
completion of PR who are not likely to benefit. Then, having distinct measures of PR 
attendance and compliance makes it possible to identify specifically where a participant’s 
difficulty in adhering to PR lies (with attendance, adherence, or both). This may also be 
useful for PR program quality assessment and improvement. 
 
The finding that the exercise regimen’s intensity moderated the relationship between 
baseline depression levels and PR exercise compliance may have implications for exercise 
prescription: participants with greater depression may comply better with moderate (as 
opposed to low or high) intensity exercise or self-selected intensities. Our finding that sex 
moderated the relationship between baseline depression levels and levels of exercise 
maintained post-PR suggests that and men with depressive symptoms may require more 
support than women with similar symptoms to maintain regular exercise. 
 
Relatively brief and focused cognitive-behavioral interventions’ effectiveness have 
begun to be investigated and some promising results have emerged (Coventry & Gellatly, 
2008; Health Quality Ontario, 2015; M. J. Hynninen, Bjerke, Pallesen, Bakke, & Nordhus, 
2010; Panagioti, Scott, Blakemore, & Coventry, 2014). Based on this study’s findings and 
the latest definition of PR (Spruit et al., 2013) these kinds of interventions should now be 
integrated into PR for COPD by qualified professionals. 
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Appendix B   
Physical Activity Diary 
  
 
 
 
 
Quelques consignes pour remplir votre journal:
!  Pendant 7 jours consécutifs, nous vous demandons d'inscrire les activités physiques que vous pratiquez pendant 
la journée.  Chacune de ces activités physiques doit être exercée pendant un minimum de 10 minutes de façon
continue ou soutenue.  Vous indiquerez la durée de l'activité dans la case appropriée.
!  Voici des exemples de types d'activités physiques: marche, vélo, baignade, jardinage, exercices de renforcement,
golf, yoga, danse, quilles, pétancle, ski, etc.  Soyez précis, par exemple: épicerie en poussant le panier à roulettes.
!  Pour chacune des activités, veuillez indiquez l'intensité à laquelle vous l'avez pratiquée.  Voici des exemples: 
! d'activités légères: vélo stationnaire sans résistance, vitesse confortable; marche de magasinage; danser un «slow»;
! d'activités modérées: danse sociale; racler des feuilles; peinturer; vélo sur route, pour le plaisir, à une vitesse 
inférieure à 10 mph ou 16 kmh;
! d'activités intenses: vélo stationnaire, effort modéré, avec une résistance de 150 watts; vélo sur route, effort 
modéré, à une vitesse d'au moins 12 mph ou 19 kmh; marche rapide militaire à 5mph ou 8kmh; pelleter.
Questions:
Est-ce que la semaine qui vient de se terminer était « typique » en ce qui a trait à votre pratique d’activités physiques?
!OUI !NON
Si NON, pour quelle raison?
! Vacances
! Exacerbation de ma maladie
! Autre maladie 
! Autre raison: expliquez ____________________________________________________________________________
De quelle façon la semaine qui vient de passer était-elle atypique?
! plus d’activités physiques que dans une semaine typique
! moins d’activités physiques que dans une semaine typique
! aucune activité physique
Veuillez s.v.p. consulter les instructions à l'endos de la feuille avant de remplir le journal.
Dimanche Lundi Mardi Mercredi Jeudi Vendredi Samedi
Dates   (j-m-a)    
Activité #1 (type)
Intensité
(légère, modérée ou élevée)
Durée 
(min)
Activité #2 (type)
Intensité
(légère, modérée ou élevée)
Durée 
(min)
Activité #3 (type)
Intensité
(légère, modérée ou élevée)
Durée 
(min)
Nom:_____________________________
Étude  «Optimisation d'un programme de réadaptation respiratoire»
Journal d'activités physiques
  
Appendix C 
Assessment of Bias, Normality, and Generalizability of Data
  
For univariate data, normality and homoscedasticity were assessed by examining 
histograms, boxplots, and P-P plots, as well as z-scores, standardized measures of 
skewness and kurtosis, and Kolmogorov-Smirnov and Shapiro-Wilk tests. For bivariate 
(i.e., correlations) and multivariate data (i.e., multiple regression analyses), normality, 
linearity, and homoscedasticity were assessed by examination of standardized residual 
scatterplots, histograms, P-P plots, and other assessments of normality available in SPSS 
23 linear regression (Cook’s distance, Mahalonobis distance, average leverage, 
standardized DFBeta and DFFit). When a multivariate outlier exerting disproportionate 
effects on the results of a regression analysis was identified, regression analyses were 
performed and presented with and without that case (Lang & Secic, 2006; Tabachnick & 
Fidell, 2013). All potential IVs to be included in the linear regression analyses were 
screened for collinearity and multicollinearity and if found, only the variable with the 
stronger association to the outcome variable was retained in the final regression model 
(Tabachnick & Fidell, 2013). 
 
One extremely high univariate outlier was found among the baseline BDI-II 
scores. When this high score was winsorized (reduced from 35 to 23) it resulted in an 
acceptable z score and more normal data distribution (see Table 12 below). 
 
 
 
 
  
Normality Assessments for Primary Analyses 
 
Table 12 
 
Assessments of Bias and Normality for Baseline BDI and Covariates Included in Regression Models 
 
 
Predictors  
 
Histogram 
shows 
 
Boxplot 
shows 
High/low 
z-scores 
(p, 2-tailed) 
P-P plot 
(Skewness/ 
Kurtosis) 
 
Skewness z 
(p, 2-tailed) 
 
Kurtosis z 
(p, 2-tailed) 
 
Kolmog-S  
(p, 2-tailed) 
 
Shapiro-W  
(p, 2-tailed) 
BDI-II 
(With high  
score =35) 
1 outlier  
CL029, 
+ skewed   [X] 
Positive skew, 
1 Extreme 
outlier        [X] 
CL029 = 3.85 
(< .001) out- 
lier           [X] 
Some skew & 
kurtosis 
[X] 
4.4 (< .001) 
very significant 
[X] 
6.85 (< .001) 
 
[X] 
.157 (.025) 
 
[X] 
.872 (.001) 
 
[X] 
BDI-II  
(High score 
winsorized*  
to 23)  
Appears normal, 
no outliers 
 
[] 
Slight + skew, 
No outliers 
 
[] 
CL029 = 2.51 
(.012) 
Acceptable 
[] 
Appears 
normal 
 
[] 
1.63 (.103) 
 
 
[] 
0.44 (.660) 
 
 
[] 
.103 (.200) 
 
 
[] 
.956 (.166) 
 
 
[] 
FEV1 % 
(n = 36) 
Quite normal 
[] 
Quite normal 
[] 
-2.19 not 
extreme     [] 
Slight skew 
[] 
-0.33 (.741) 
[] 
-1.02 (.308) 
[] 
.091 (.200) 
[] 
.974 (.538) 
[] 
HLC-op 
(n = 36) 
Some + skew 
[] 
Some + skew, 
No outliers[] 
2.05 not 
extreme     [] 
Quite normal 
[] 
1.02  (.308) 
[] 
-0.84 (.401) 
[] 
.094 (.200) 
[] 
.948 (.089) 
[] 
HLC-c 
(n = 36) 
Looks normal 
[] 
Very normal 
[] 
1.92 not 
extreme     [] 
Very normal 
[] 
0.21 (.834) 
[] 
-0.82 (.412) 
[] 
.083 (.200) 
[] 
.978 (.666) 
[] 
Note. N = 36. Assessments are presented for baseline BDI scores including extreme outlier and with that score winsorized. Kolmog-S = Kolmogorov-Smirnov 
test; Shapiro-W = Shapiro Wilk test; + = positively; BDI-II = Beck Depression Inventory; *Assigned CL029 a BDI score value of 23 instead of 35 (2 units higher 
than the next highest score, so less extreme); [] Normal, not cause for concern; [X] Non-normal, cause for concern. 
  
1
2
4
 
Assessments of bias and normality for PR attendance and Compliance data are presented in Table 13 below. Bootstrapping is 
indicated for analyses involving this outcome because of the non-normal negatively skewed data distributions and several outlying 
scores.  
 
Table 13 
 
Assessments of Bias and Normality for Univariate PR Program Data 
PR 
Program 
Outcomes Histogram Boxplot 
High/low 
z-scores 
P-P plot 
(Skewness/ 
Kurtosis) 
Skewness z 
(p, 2-tailed) 
Kurtosis z 
(p, 2-tailed) 
Kolmog-S  
(p, 2-tailed) 
Shapiro-W 
z(p, 2-tailed) 
Attend PR 
(n = 36) 
Neg skew 
Outliers not 
obvious      [X] 
 bootstrap 
Neg skew , 4 
outliers 
                  [X] 
 bootstrap 
-2.67, -2.57, 
02.27: 
abnormal  [X] 
 bootstrap 
Shows skew 
(“S” shape) 
                   [X] 
 bootstrap 
-3.79 (< .001) 
 
                   [X] 
 bootstrap 
1.89 (.059) 
 
                    [] 
 
.200 (.001) 
 
                   [X] 
 bootstrap 
.807 (< .001) 
 
                   [X] 
 bootstrap 
Comply PR 
(n = 36) 
Neg skew, 
possible outliers      
[X] 
 bootstrap 
Neg skew,  
6 non-extreme 
outliers      [X] 
 bootstrap 
-2.24 x 3, -
2.10         not 
normal      [X] 
 bootstrap 
Shows skew 
(“S” Shape) 
                   [X] 
 bootstrap 
-3.61 (< .001) 
 
                   [X] 
 bootstrap 
0.69 (.490) 
 
                    [] 
 
.267 (< .001) 
 
                   [X] 
 bootstrap 
.705 (< .001) 
 
                   [X] 
 bootstrap 
Note. N = 36. Kolmog-S = Kolmogorov-Smirnov test; Shapiro-W = Shapiro-Wilk test; Attend PR = Attendance at pulmonary rehabilitation; Comply PR = 
Compliance at pulmonary rehabilitation; Neg = negative; [] Normal, not cause for concern; [X] Non-normal, cause for concern. 
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The assessments of bias and normality for the follow-up exercise level data (Table 14 below) reveal a positively skewed 
distribution and justify using bootstrapping in analyses. 
 
Table 14 
 
Assessments of Bias and Normality for Follow-Up Exercise Levels Data 
Follow-Up 
post-PR 
Outcome Histogram Boxplot 
High/low 
z-scores 
P-P plot 
(Skewness/ 
Kurtosis) 
Skewness z 
(p, 2-tailed) 
Kurtosis z 
(p, 2-tailed) 
Kolmog-S z 
(p, 2-tailed) 
Shapiro-W z 
(p, 2-tailed) 
Exercise in 
METmins 
(n = 36) 
 
+ skew, one 
possible outlier 
                     [X] 
 bootstrap 
+ skew LD008 
is extreme 
outlier        [X] 
 bootstrap 
LD008 = 2.92 
(p = .004) is  
an outlier 
                 [X] 
Some skew, 
“S” shape 
Abnormal   [X] 
 bootstrap 
3.35 (< .001) 
sig. skew 
                   [X] 
 bootstrap 
1.88 (.060) 
               
                   [] 
.181 (.004) 
 
                  [X] 
 bootstrap 
.878 (.001) 
 
                   [X]  
 bootstrap 
Note. N = 36. Kolmog-S = Kolmogorov-Smirnov test; Shapiro-W = Shapiro Wilk test;  METmins = Metabolic Equivalent of Task minutes (measure of amount of 
exercise performed); [] Normal, not cause for concern; [X] Non-normal, cause for concern. 
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Bias, normality, and generalizability of assessments of PR attendance regressed on baseline BDI-II (see Table 15 below) justify 
winsorizing one extreme baseline BDI-II high score (35) which would otherwise exert substantial influence on analyses. 
 
Table 15 
 
Assessment of Bias, Normality, and Generalizability for the Simple Regression of  
Baseline BDI-II (High BDI-II Outlier in Data Set) Predicting PR Attendance 
Standardized 
Residuals Cook’s Distance 
 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
CM034 = -2.64 
(p = .008) 
Outlier, but not  
extreme              [X]                         
LD012 = .19 
highest, but < 1      
OK 
       [] 
 CL029 = 14.83 > 
Cutoff = 6.64, df=1, 
p = .01   Outlier 
                           [X] 
CL029 = .42, ( > 
.11, critical value)   
  Outlier   
                          [X] 
All values < 2  
          
 
                           [] 
All values < 2  
 
 
                           [] 
CL029 = 1.92 (0.83 to 
1.17 is ideal) so undue 
influence 
                           [X] 
 
Durban-Watson Test 
(for independent errors) 
Residuals Analyses 
(for stand regression analysis) 
Multicollinearity 
(Doesn’t apply because bivariate) 
2.27 (values between 1 to 3 
acceptable, so OK) 
                                                      [] 
Histogram: very  - skew                 [X] 
P-P Plot: abnormal [X],  Zpred Zresid 
heteroscedastic, CL029 outlier     [X] 
 bootstrap 
Greatest Pearson r among predictors                                                               [] 
Tolerance: lowest value = 1.0    VIF: largest value = 1.0                                [] 
Each predictor’s variance proportion is distributed across diff dimensions    [] 
Note. N = 36. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; VIF = variable inflation factor. 
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Table 16 shows that winsorizing the outlying high baseline BDI-II score from 35 to 23 reduces bias and improves 
generalizability of the simple regression of PR attendance (outcome) regressed on baseline BDI-II. 
 
Table 16 
 
Assessment of Bias, Normality, and Generalizability for the Simple Regression of  
Baseline BDI-II (High Outlier Winsorized) Predicting PR Attendance 
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
CM034 = -2.63 
(p = .009) 
Outlier, but not  
extreme              [X]                         
LD012 = .23 
highest, but < 1      
OK 
       [] 
 CL029 = 6.32 < 
Cutoff = 6.64, df=1, 
p = .01    Outlier 
                           [] 
CL029 = .18, ( > 
.11, critical value)   
  Outlier  
                          [X] 
All values < 2  
          
 
                           [] 
All values < 2  
 
 
                           [] 
CL029 = 1.33 (0.83 
to 1.17 is ideal) 
slight influence, but 
OK                     [] 
 
Durban-Watson Test 
(for independent errors) 
Residuals Analyses 
(for stand regression analysis) 
Multicollinearity 
(Doesn’t apply because bivariate) 
2.26 (values between 1 to 3 
acceptable, so OK) 
                                                      [] 
Histogram: very  - skew                [X] 
P-P Plot: abnormal [X],  Zpred Zresid 
heteroscedastic, but no outlier     [X] 
 bootstrap 
Greatest Pearson r among predictors                                                               [] 
Tolerance: lowest value = 1.0    VIF: largest value = 1.0                                [] 
Each predictor’s variance proportion is distributed across diff dimensions    [] 
Note. N = 36. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; VIF = variable inflation factor. 
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Bias, normality, and generalizability of assessments of PR exercise compliance regressed on baseline BDI-II (see Table 17 
below) show that winsorizing one extreme baseline BDI-II high score of 35 is justified to reduce its exerting substantial influence on 
bivariate analyses. 
 
Table 17 
 
Assessment of Bias, Normality, and Generalizability for the Simple Regression of Baseline  
BDI-II (High Outlier in Data Set) Predicting PR Exercise Compliance  
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
GC036 = -2.55 
(p = .011) 
Acceptable 
                           [X]                         
CL029 = .47 
highest, but < 1      
OK 
                       [] 
 CL029 = 14.83 > 
(Cutoff = 6.64, 
df=1, p = .01)    
Extreme Outlier [X] 
CL029 = .42, ( > 
.11, critical value)   
  Outlier  
                          [X] 
All values < 2  
CL029 = -0.94 
 
                           [] 
All values < 2  
CL029 = -0.97 
 
                           [] 
CL029 = 1.81 (0.83 to 
1.17 is ideal)  
Very influential 
                           [X] 
 
Durban-Watson Test 
(for independent errors) 
Residuals Analyses 
(for stand regression analysis) 
Multicollinearity 
(Doesn’t apply because bivariate) 
1.35 (values between 1 to 3 
acceptable, so OK) 
                                                      [] 
Histogram: very  - skewed            [X] 
P-P Plot: abnormal [X],  Zpred Zresid 
heteroscedastic, CL029 outlier    [X] 
 bootstrap 
Greatest Pearson r among predictors                                                               [] 
Tolerance: lowest value = 1.0    VIF: largest value = 1.0                                [] 
Each predictor’s variance proportion is distributed across diff dimensions    [] 
Note. N = 36. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; VIF = variable inflation factor. 
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Table 18 shows that winsorizing the outlying high baseline BDI-II score (from 35 to 23) reduces bias and improves 
generalizability of the simple regression of PR exercise compliance regressed on baseline BDI-II. 
 
Table 18 
 
Assessment of Bias, Normality, and Generalizability for the Simple Regression of Baseline  
BDI-II (With Outlier Winsorized) Predicting PR Exercise Compliance  
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
GC036 = -2.55 
(p = .011) 
Acceptable         [X]                         
CL029 = .33 
highest, but < 1      
OK                      [] 
 CL029 = 6.32 < 
(Cutoff = 6.64, 
df=1, p = .01)      [] 
CL029 = .18,  (> 
.11, critical value)   
  Slight outlier    [X] 
All values < 2  
CL029 = -0.77 
                           [] 
All values < 2  
CL029 = -0.83 
                           [] 
CL029 = 1.15 (0.83 to 
1.17 is ideal)  
                           [] 
 
Durban-Watson Test 
(for independent errors) 
Residuals Analyses 
(for stand regression analysis) 
Multicollinearity 
(Doesn’t apply because bivariate) 
1.39 (values between 1 to 3 
acceptable, so OK) 
                                                      [] 
Histogram:          - skewed            [X] 
P-P Plot: abnormal [X],  Zpred Zresid 
heteroscedastic, but no outlier     [X] 
 bootstrap 
Greatest Pearson r among predictors                                                               [] 
Tolerance: lowest value = 1.0    VIF: largest value = 1.0                                [] 
Each predictor’s variance proportion is distributed across diff dimensions    [] 
Note. N = 36. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; VIF = variable inflation factor. 
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Table 19 presents results of bias, normality, and generalizability assessments for follow-up exercise levels regressed on baseline 
BDI-II scores. An extreme bivariate outlier exerting substantial influence is revealed. 
 
Table 19 
 
Assessment of Bias, Normality, and Generalizability for Simple Regression of Baseline BDI-II (High Outlier in Data Set)  
Predicting Exercise Levels at Follow-Up (With bivariate Outlier in Data Set)  
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
LD008 = 3.49 
(p < .001) 
Extreme Outlier 
                           [X]                         
LD008 = .89  
< 1, influential, but 
acceptable   
                       [] 
 CL029 = 14.83 > 
Cutoff = 6.64 (df=1) 
p = .01) 
                           [X] 
CL029 = .42, (lot > 
.11, critical value)   
                           
                          [X] 
LD008 = 1.48 > 1  
Some influence           
 
                           [X] 
LD008 = 1.70 > 1  
Some influence 
 
                           [X] 
LD008 = 0.43 CL029 
= 1.92 (.083 
to 1.17  ideal) so 
much influence  [X] 
 
Durban-Watson Test 
(for independent errors) 
Residuals Analyses 
(for stand regression analysis) 
Multicollinearity 
(Doesn’t apply because bivariate) 
1.96 (values between 1 to 3 
acceptable, so OK) 
                                                       [] 
Histogram: looks + skew, outlier  [X] 
P-P Plot: abnormal [X],  Zpred Zresid 
heteroscedastic, LD008 outlier    [X] 
 bootstrap 
Greatest Pearson r among predictors                                                               [] 
Tolerance: lowest value = 1.0    VIF: largest value = 1.0                                [] 
Each predictor’s variance proportion is distributed across diff dimensions    [] 
Note. N = 36. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; + = positive VIF = variable inflation factor. 
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Table 20 presents results of bias, normality, and generalizability assessments for follow-up exercise levels regressed on baseline 
BDI-II scores with the high BDI-II score winsorized (from 35 to 23), however the extreme bivariate outlier remains influential.  
  
Table 20 
 
Assessment of Bias, Normality, and Generalizability for the Simple Regression of Baseline BDI-II Predicting Exercise 
 Levels at Follow-Up (Bivariate Outlier in Data Set and the High BDI-II Score Winsorized) 
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
LD008 = 3.63 
(p < .001) 
Extreme Outlier 
                           [X]                         
LD008 = 1.49  
> 1, much influence   
   
                           [X] 
 LD008 = 4.63 < 
Cutoff = 6.64 (df=1) 
p = .01) 
                           [] 
LD008 = .13, 
CL029 = .18 ( >.11  
critical value)   
                           [X] 
LD008 = 2.11 > 2 ( 
much influence           
 
                           [X] 
LD008 = 2.11 > 2  
much influence 
 
                           [X] 
LD008 = 0.37 
CL029 = 1.34 (0.83 
to 1.17 ideal) so 
much influence [X]                    
 
Durban-Watson Test 
(for independent errors) 
Residuals Analyses 
(for stand regression analysis) 
Multicollinearity 
(Doesn’t apply because bivariate) 
2.00 (values between 1 to 3 
acceptable, so OK) 
                                                   [] 
Histogram: looks + skewd, outlier  [X] 
P-P Plot: abnormal [X],  Zpred Zresid 
heteroscedastic, LD008 outlier      [X] 
 bootstrap 
Greatest Pearson r among predictors                                                               [] 
Tolerance: lowest value = 1.0    VIF: largest value = 1.0                                [] 
Each predictor’s variance proportion is distributed across diff dimensions    [] 
Note. N = 36. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; + = positive; VIF = variable inflation factor.  
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Table 21 presents results of bias, normality, and generalizability assessments for follow-up exercise levels regressed on baseline 
BDI-II scores with the extreme bivariate outlier removed, but with the high outlying baseline BDI-II score not winsorized. The level of 
bias and non-normality is problematic and again justifies winsorizing the outlying high baseline BDI-II score. 
 
Table 21 
 
Assessment of Bias, Normality, and Generalizability for the Simple Regression of Baseline BDI-II Predicting Exercise Level 
 at Follow-Up (Bivariate Outlier Removed and High BDI-II Outlier in the Data Set) 
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
JV069 = 2.54 
(p = .011) 
Not too unusual  
                           [] 
JV069 = 2.17 is 
highest, Much > 1   
So very great 
influence            [X] 
CL029 = 16.23 
Cutoff = 6.64  
(df=1, p=.01) 
Very distant       [X] 
CL029 = .48 is 
highest (> .11, 
critical value)  
                          [X] 
CL029 highest = 
2.13 >  2  
Influential             
                           [X] 
CL029 highest = 
2.2 > 2 
 
                           [X] 
CL029 = 1.64 (0.83 
to 1.17 is ideal) 
 
                           [X] 
 
Durban-Watson Test 
(for independent errors) 
Residuals Analyses 
(for stand regression analysis) 
Multicollinearity 
(Doesn’t apply because bivariate) 
1.46 (values between 1 to 3 
acceptable, so OK) 
                                                       [] 
Histogram:  slight + skew             [X] 
P-P Plot: not normal                      [X]          
Zpred Zresid heteroscedastic       [X] 
 bootstrap 
Greatest Pearson r among predictors                                                               [] 
Tolerance: lowest value = 1.0    VIF: largest value = 1.0                                [] 
Each predictor’s variance proportion is distributed across diff dimensions    [] 
Note. N = 35. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; + = positive; VIF = variable inflation factor. 
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Removal of the bivariate outlier and winsorizing the high baseline BDI-II score reveals improvement in bias, normality, and 
generalizability of the simple regression of baseline BDI-II predicting exercise level at follow-up, though bootstrapping is still 
indicated (see Table 22 below). 
  
Table 22 
 
Assessment of Bias, Normality, and Generalizability for the Simple Regression of Baseline BDI-II Predicting Exercise  
Level at Follow-Up (Bivariate Outlier Removed and High BDI-II Outlier Winsorized) 
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
JV069 = 2.48 
(p = .013) 
Not too unusual  
                           [] 
JV069 = 0.23 is 
highest, Much < 1   
OK 
                           [] 
CL029 = 7.46 
Cutoff = 6.64  
(df=1, p=.01) 
                          [X] 
CL029 = .22 is 
highest (.11, critical 
value)  
                          [X] 
CL029 highest = 
0.58 < 2, OK  
                           
                           [] 
JV069 highest = 
0.73 < 2, OK 
 
                           [] 
JV069 = 0.73 (0.83 to 
1.17 is ideal), OK 
 
                           [] 
 
Durban-Watson Test 
(for independent errors) 
Residuals Analyses 
(for stand regression analysis) 
Multicollinearity 
(Doesn’t apply because bivariate) 
1.56 (values between 1 to 3 
acceptable, so OK) 
                                                       [] 
Histogram:  slight + skew             [X] 
P-P Plot: quite normal                   []          
Zpred Zresid heteroscedastic      [X] 
 bootstrap 
Greatest Pearson r among predictors                                                               [] 
Tolerance: lowest value = 1.0    VIF: largest value = 1.0                                [] 
Each predictor’s variance proportion is distributed across diff dimensions    [] 
Note. N = 35. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; + = positive; VIF = variable inflation factor.  
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Bias, normality, and generalizability assessments for the regression of baseline BDI-II and covariates predicting PR attendance 
reveal that the outlying high BDI-II score of 35 exerts substantial influence on the model (see table 23), which justified it being 
winsorized from 35 to 23.  
 
Table 23 
Assessment of Bias, Normality, and Generalizability for the Multiple Regression Model of BDI-II (Extreme High Score in Data) 
 and Covariates Predicting PR Attendance 
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
LD012 = -2.28 
(p = .023) 
Not too unlikely             
                           [] 
0.32 is highest < 1  
  
                           [] 
 CL029 = 17.53 
Cutoff =16.8 (df=6, 
p=.01), high 
leverage             [X] 
CL029 = .50 is 
highest (< .58, 
critical value)  OK 
                           [] 
LD012 = 1.1 
absolute value < 2 
for (highest value)  
                           [] 
LD012 = -1.69 < 2 
acceptable                            
 
                          [] 
LD012 = .25  
CL029 = 2.22 
(0.42 to 1.6 ideal)  
                           [X] 
 
Durban-Watson Test 
(for independent errors) 
Residuals Analyses 
(for stand regression analysis) Multicollinearity 
2.0 (values between 1 to 3 
acceptable, so OK) 
                                                      [] 
Histogram:  some skew                  [] 
P-P Plot: skew [X],   Zpred Zresid 
heteroscedastic, no outlier           [X] 
 bootstrap 
Greatest Pearson r among predictors (FEV1% & IT) = -.362 (p = .031)         [] 
Tolerance: lowest value = 0.548    VIF: largest value = 1.824                        [] 
Each predictor’s variance proportion is distributed across diff dimensions    [] 
Note. N = 36. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; VIF = variable inflation factor. 
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Table 24 shows that winsorizing the extreme outlying baseline BDI-II score from 35 to 23 helps reduce bias and produces a 
model that is more representative of the sample. 
 
Table 24 
 
Assessment of Bias, Normality, and Generalizability for the Multiple Regression Model of BDI-II (High Score Winsorized)  
and Covariates predicting PR Attendance 
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
LD012 = -2.23 
(p = .026) 
Not too unlikely             
                           [] 
LD012 is highest = 
0.34 < 1, OK 
                           [] 
 CL029 = 10.13 
Cutoff =16.81 
(df=6, p=.01), OK 
                           [] 
CL029 = .29 is 
highest (< .39, 
critical value)  OK 
                           [] 
LD012 = .57 
highest, absolute 
value < 2  
                           [] 
LD012 = -1.75, 
absolute value < 2, 
OK                             
                           [] 
LD012 = .25  
CL029 = 1.36 
(0.42 to 1.6 ideal)  
                           [X] 
 
Durban-Watson Test 
(for independent errors) 
Residuals Analyses 
(for stand regression analysis) Multicollinearity 
1.97 (values between 1 to 3 
acceptable, so OK) 
                                                      [] 
Histogram:  some neg. skew          [] 
P-P Plot: skew [X],    Zpred Zresid 
heteroscedastic, no outlier           [X] 
 bootstrap 
Greatest Pearson r among predictors (FEV1% & IT) = -.361 (p = .031)         [] 
Tolerance: lowest value = 0.546    VIF: largest value = 1.831                        [] 
Each predictor’s variance proportion is distributed across diff dimensions    [] 
Note. N = 36. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; neg. = negative; VIF = variable inflation factor. 
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Table 25 reveals that the high outlying baseline BDI-II score exerts substantial influence on the regression model predicting PR 
exercise compliance and justifies winsorizing it from 35 to 23 to reduce its substantial influence. 
 
Table 25 
 
Assessment of Bias, Normality, and Generalizability for the Multiple Regression Model of BDI-II  
(High Score in Data) and Covariates Predicting PR Exercise Compliance  
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
CM034 = -2.41  
(p = .016) 
somewhat unlikely            
but OK                [] 
CM034 = .18 
highest (all < 1 so 
OK)                           
                           [] 
 CL029 = 17.53 > 
Cutoff = 16.8 (df = 
6, p = .01): cause 
for concern        [X] 
CL029 = .50 (> .38, 
critical value) exerts 
undue influence                            
                           [X] 
All values < 2 so no 
case exerts undue 
influence on model 
parameters          [] 
All values < 2 
 
 
                           [] 
CM034 = .23, 
CL029 = 2.68 
(0.42 to 1.6 ideal) 
Some influence  [X] 
 
Durban-Watson Test 
(for independent errors) Residuals Analyses Multicollinearity 
2.01 (values between 1 to 3 
acceptable, so OK) 
                                                       [] 
Histog shows near normal distrib  [] 
P-P Plot std residual some skew   [X] 
Zpred Zresid some heteroscedast  [X] 
 bootstrap 
Greatest Pearson r among predictors (IT & FEV1 %) = -.36 (p = .031)          [] 
Tolerance: lowest value = 0.79    VIF: largest value = 1.26                            [] 
Each predictor’s variance proportion distributed across diff dimensions        [] 
Note. N = 36. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; std = standardized; VIF = variable inflation factor. 
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Table 26 shows that bias, normality, and generalizability of the regression analysis of baseline BDI-II and covariates predicting 
PR exercise compliance are improved when the BDI-II outlying high score is winsorized from 35 to 23. 
 
Table 26 
 
Assessment of Bias, Normality, and Generalizability for the Multiple Regression Model of BDI-II  
 (High Score Winsorized) and Covariates Predicting PR Exercise Compliance  
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
CM034 = -2.17  
(p = .030) 
somewhat unlikely            
                           [] 
CM034 = .15, 
highest (all < 1 so 
OK) 
                           [] 
 CL029 = 10.13 < 
Cutoff = 16.8 (df = 
6, p = .01) 
                           [] 
CL029 = .29 (< .38, 
critical value)    OK 
                            
                         [] 
All values < 2 so no 
case exerts undue 
influence  
                           [] 
All values < 2 
 
 
                           [] 
CM034 = .34, CL029 
= 1.39 
(0.42 to 1.58 ideal) 
                          [X] 
 
Durban-Watson Test 
(for independent errors) Residuals Analyses Multicollinearity 
2.06 (values between 1 to 3 
acceptable, so OK) 
                                                       [] 
Histog shows near normal distrib  [] 
P-P Plot std residual some skew   [X] 
Zpred Zresid some heteroscedast  [X] 
 bootstrap 
Greatest Pearson r among predictors (IT & FEV1 %) = -.36 (p = .031)          [] 
Tolerance: lowest value = 0.79    VIF: largest value = 1.26                            [] 
Each predictor’s variance proportion distributed across diff dimensions        [] 
Note. N = 36. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; std = standardized; VIF = variable inflation factor. 
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Table 27 reveals a multivariate outlier exerting substantial influence on the regression model of baseline BDI-II (extreme high 
score in) and covariates predicting exercise levels at follow-up, thus justifying repeating the regression with the multivariate outlier 
removed. 
 
Table 27 
 
Assessment of Bias, Normality, and Generalizability for the Regression Model of BDI-II (High Score Included)  
and Covariates Predicting Exercise Levels at Follow-Up 
Standardized 
Residuals 
 Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
LD008 = 3.26 
(p = .001)  
Unlikely             
                           [X] 
LD008 = .5, < 1 but 
is greatest 
  
                           [] 
CL029 = 17.53 
Cutoff = 16.8,  
(df=6,  p=.01)      
                            [X] 
CL029 = .50 is 
highest (> critical 
value of .38) 
                           [X] 
LD008=1.61, high 
Substantial 
influence  
                           [X] 
LD008 = 2.51 > 2, 
Influential case 
 
                           [X] 
LD008 =  .02, low  
(< 0.41 considered 
problematic)  
                         [X] 
 
Durban-Watson Test 
(for independent errors) 
Residuals Analyses 
(for stand regression analysis) Multicollinearity 
2.14 (values between 1 to 3 
acceptable, so OK) 
                                                      [] 
Histogram: positively skewed       [X] 
P-P Plot: skew                               [X]    
Zpred Zresid heteroscedastic       [X] 
 bootstrap 
Greatest Pearson r among predictors (FEV1% pred & IT) = -.36 (p = .031)   [] 
Tolerance: lowest value = 0.55    VIF: largest value = 1.82                            [] 
Distribution of variance proportions across dimensions                                  [] 
Note. N = 36. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; VIF = variable inflation factor. 
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Table 28 reveals there is still considerable bias remaining, despite removal of the influential multivariate outlier. This bias is due 
to the presence of the extreme high outlying baseline BDI-II score and justifies winsorizing it from 35 to 23. 
 
Table 28 
 
Assessment of Bias, Normality, and Generalizability for the Multiple Regression Model of BDI-II (High Score Included) and 
Covariates Predicting Exercise Levels at Follow-up (Influential Mutivariate Outlier Removed) 
Standardized 
Residuals 
 Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
JV069 = 2.25 
(p = .024)  
Acceptable             
                           [] 
CL029 = .38 is 
greatest, but < 1.0 
  
                           [] 
CL029 = 19.05 
Cutoff = 16.8,  
(df = 6,  p = .01)      
                            [X] 
CL029 = .56 is 
highest (>  critical 
value of .38) 
                           [X] 
CL029=1.43 for 
BDI 
  
                           [] 
CL029 = 1.65 < 2, 
 
 
                           [] 
JV069=.28, lowest 
(< 0.4 considered 
problematic)  
                         [X] 
 
Durban-Watson Test 
(for independent errors) 
Residuals Analyses 
(for stand regression analysis) Multicollinearity 
1.69 (values between 1 to 3 
acceptable, so OK) 
                                                      [] 
Histogram: Appears normal           [] 
P-P Plot: Some skew                      [X]    
Zpred Zresid heteroscedastic        [X] 
 bootstrap 
Greatest Pearson r among predictors (FEV1% pred & IT) = -.35 (p = .038)   [] 
Tolerance: lowest value = 0.54    VIF: largest value = 1.87                            [] 
Distribution of variance proportions across dimensions                                  [] 
Note. N = 35. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; VIF = variable inflation factor. 
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Table 29 reveals considerable bias for the multiple regression model of BDI-II (high score winsorized) and covariates predicting 
exercise levels at follow-up, with the multivariate outlier in the data set. 
 
Table 29 
 
Assessment of Bias, Normality, and Generalizability for the Multiple Regression Model of BDI-II (High Score Winsorized) and 
Covariates  Predicting Exercise Levels at Follow-up (Influential Mutivariate Outlier in Data Set) 
Standardized 
Residuals 
 Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
LD008 = 3.29 
(p = .001)  
Not acceptable             
                           [X] 
LD008 = .72 is 
greatest, but < 1.0 
  
                           [] 
CL029 = 10.13 
LD008 = 8.00, Cut- 
off = 16.8,  (df = 6,  
p = .01)              [X] 
LD008 = .23 is 
highest (< critical 
value of .38) 
                           [] 
LD008 = 2.25 for 
BDI (> critical 2) 
  
                           [X] 
LD008 = 3.12  
Much > 2 
 
                           [X] 
LD008=.01, lowest 
(< 0.4 considered 
problematic)  
                         [X] 
 
Durban-Watson Test 
(for independent errors) 
Residuals Analyses 
(for stand regression analysis) Multicollinearity 
2.12 (values between 1 to 3 
acceptable, so OK) 
                                                      [] 
Histogram: Appears + skewed       [X] 
P-P Plot: skewed                             [X]    
Zpred Zresid heteros, outlier        [X] 
 bootstrap 
Greatest Pearson r among predictors (FEV1% pred & IT) = -.35 (p = .038)   [] 
Tolerance: lowest value = 0.55    VIF: largest value = 1.83                            [] 
Distribution of variance proportions across dimensions                                  [] 
Note. N = 35. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; + = positive; VIF = variable inflation factor. 
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Removing the multivariate outlier and winsorizing the extreme high baseline BDI-II score greatly reduces the bias and helps 
produce a regression model that is more accurate and representative of out sample, as can be seen from Table 30 below. 
 
Table 30 
 
Assessment of Bias, Normality, and Generalizability for the Multiple Regression Model of BDI-II (High Score Winsorized) and 
Covariates Predicting Exercise Levels at Follow-Up (Multivariate Outlier Removed) 
Standardized 
Residuals 
 Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
JV069 = 2.21 
(p = .027)  
Acceptable             
                           [] 
JV069 = .18 is 
greatest, but < 1.0 
  
                           [] 
CL029 = 11.45 
Cutoff = 16.8,  
(df = 6,  p = .01)      
                            [] 
CL029 = .34 is 
highest (< critical 
value of .6) 
                           [] 
JV069=1.1 for  
Intercept 
 
                           [] 
CL029 = 1.25 < 2, 
 
 
                           [] 
JV069=.30, lowest 
(< 0.4 considered 
problematic)  
                         [X] 
 
Durban-Watson Test 
(for independent errors) 
Residuals Analyses 
(for stand regression analysis) Multicollinearity 
1.73 (values between 1 to 3 
acceptable, so OK) 
                                                      [] 
Histogram: Appears not normal     [X] 
P-P Plot: Some skew                      [X]    
Zpred Zresid heteroscedastic        [X] 
 bootstrap 
Greatest Pearson r among predictors (FEV1% pred & IT) = -.35 (p = .038)   [] 
Tolerance: lowest value = 0.54    VIF: largest value = 1.86                            [] 
Distribution of variance proportions across dimensions                                  [] 
Note. N = 35. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; VIF = variable inflation factor. 
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Normality Assessments for Exploratory/Secondary Analyses: 
Below are tables presenting assessments of bias, normality, and generalizability for data in the regression models made up of the 
strongest baseline predictors of PR attendance, PR compliance, and exercise levels at follow-up. Table 31 shows only slight bias not 
requiring any transformation of values, but that bootstrapping should be used to as assumptions of normally distributed residuals appear 
to have not been satisfied. 
 
Table 31 
 
Assessment of Bias, Normality, and Generalizability for Regression Model Predicting PR attendance  
from Baseline FEV1 %, Cohabiting Status, and HLC Other People 
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
LD012 = -2.11 
(p = .035) 
Normal enough 
                           [] 
LD012 = .21, 
highest (all < 1 so 
OK) 
                           [] 
FB007 = 9.49  
Cutoff = 11.34 (df = 
3, p = .01): not ext-
treme outlier       [] 
FB007 = .27 (> .22, 
critical value) slight 
influence  
                           [] 
All absolute values 
< 1 
 
                           [] 
All absolute values 
< 1  
 
                           [] 
FB007 = 1.61 
 LD012 = 0.65 
(0.67 – 1.33 is OK) 
acceptable           [] 
 
Durban-Watson Test 
(for independent errors) Residuals Analyses Multicollinearity 
1.75 (values between 1 to 3 
acceptable, so OK) 
                                                       [] 
Histogram: little skew                    [] 
P-P Plot std residual skewed         [X] 
Zpred Zresid: some heterscedast   [X] 
 bootstrap 
Greatest Pearson r among predictors (FEV1 % & cohabiting) = -.3 (p = .08)  [] 
Tolerance: lowest value = 0.90    VIF: largest value = 1.11                             [] 
Each predictor’s variance proportion distributed across diff dimensions        [] 
Note. N = 36. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; VIF = variable inflation factor.  
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Data used in the best regression predicting PR exercise compliance were assessed for bias and normality (see Table 32 below). An 
influential case with an outlying high baseline BDI-II score was revealed that justified repeating the regression with that score winsorized 
from 35 to 23. 
 
Table 32 
 
Assessment of Bias, Normality, and Generalizability for the Regression Model Predicting PR Exercise Compliance from Baseline BDI-
II (High Score in Data), IT and CTHi Protocols, Sex, and FEV1 % 
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
CM034 = -2.43 
(p = .015) 
Normal, expected             
                           [] 
CM034 = .15 is 
highest (all < 1 so 
OK) 
                           [] 
 CL029 = 16.24 > 
Cutoff = 15.09 (df = 
5, p = .01): cause 
for concern       [X] 
CL029 = .464 (> 
.333, critical value) 
may exert undue 
influence           [X] 
All values < 2 
 
 
                           [] 
All values < 2 
 
 
                           [] 
CL029 = 2.39 is cause 
for concern 
(0.5 – 1.5 is OK) 
                          [X] 
 
Durban-Watson Test 
(for independent errors) Residuals Analyses Multicollinearity 
2.02 (values between 1 to 3 
acceptable, so OK) 
                                                       [] 
Histog shows near normal distrib  [] 
P-P Plot std residual fairly normal [] 
Zpred Zresid some heteroscedast  [X] 
 bootstrap 
Greatest Pearson r among predictors (IT & CTHi) = -.50 (p = .002)              [] 
Tolerance: lowest value = 0.59    VIF: largest value = 1.69                            [] 
Each predictor’s variance proportion distributed across diff dimensions        [] 
Note. N = 36. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; std = standardized; VIF = variable inflation factor. 
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As can be seen from results of the bias and normality assessments in Table 33 below, winsorizing the outlying high baseline BDI-
II score from 35 to 23 resulted in substantially reducing the substantial influence and producing a regression model that is more 
representative of our sample. 
 
 
Table 33 
 
Assessment of Bias, Normality, and Generalizability for the Regression Model Predicting PR Exercise Compliance from Baseline BDI-
II (High Score Winsorized), IT and CTHi Protocols, Sex, and FEV1 %  
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
CM034 = -2.23 
(p = .026) 
Normal, expected             
                           [] 
MP060 = .15, 
highest (all < 1 so 
OK) 
                           [] 
 CL029 = 8.38 < 
Cutoff = 15.09 (df = 
5, p = .01) 
                           [] 
CL029 = .24 (< 
.333, critical value) 
 
                           [] 
All values < 1 so no 
case exerts undue 
influence on model 
parameters          [] 
MP060 = 0.99 has 
highest absolute 
value: < 2 
                           [] 
CL029 = 1.30 
(0.5 – 1.5 is OK) 
 
                          [] 
 
Durban-Watson Test 
(for independent errors) Residuals Analyses Multicollinearity 
2.04 (values between 1 to 3 
acceptable, so OK) 
                                                       [] 
Histog shows near normal distrib  [] 
P-P Plot std residual fairly normal [] 
Zpred Zresid some heteroscedast  [X] 
 bootstrap 
Greatest Pearson r among predictors (IT & CTHi) = -.50 (p = .002)              [] 
Tolerance: lowest value = 0.59    VIF: largest value = 1.69                            [] 
Each predictor’s variance proportion distributed across diff dimensions        [] 
Note. N = 36. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; std = standardized; VIF = variable inflation factor. 
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Table 34 presents bias and normality assessments of data for the strongest regression model predicting exercise levels at follow-
up. Clearly, there is a problem with bias, the source of which appears to be two cases: One is the outlying high baseline BDI-II score of 
35, the other was previously identified as a multivariate outlier. 
  
Table 34 
 
Assessment of Bias, Normality, and Generalizability for the Regression Model Predicting Exercise Levels at Follow-Up from BDI-II 
(High Score in), Smoking Status, HLC Chance (With Multivariate Outlier in Data Set) 
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
LD008 = 3.79 
(p < .001) 
Very unlikely             
                           [X] 
LD008 =.63 highest 
but < 1 
 
                           [] 
 CL029 = 15.93 is 
furthest case from 
centroid. Cutoff = 
11.34  (df=3, p=.01)  
                           [X]              
CL029 = .46 is 
highest ( .33 is 
critical value), so 
big influence      [X] 
LD008= 1.9 highest  
for BDI, big 
influence on model 
parameters         [X] 
LD008 = 2.25 much 
> 1, suggests is 
influential case 
                           [X] 
LD008 = .07 Much < 
cutoff (0.67 to 1.33 
ideal) 
CL029 = 2.09  [X] 
 
Durban-Watson Test 
(for independent errors) Residuals Analyses Multicollinearity 
2.18 (values between 1 to 3 
acceptable, so OK) 
                                                      [] 
Histogram:  looks + skewed          [X] 
P-P Plot: abnormal [X]   Zpred Zresid 
heteroscedastic, LD008 outlier    [X] 
 bootstrap 
Greatest Pearson r among predictors (BDI & HLC chance) = .12 (p = .49)    [] 
Tolerance: lowest value = 0.97    VIF: largest value = 1.03                             [] 
Each predictor’s variance proportion is distributed across diff dimensions     [] 
Note. N = 36. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; + = positive; VIF = variable inflation factor. 
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Table 35 presents bias and normality assessments for the regression analysis predicting exercise levels at follow-up, but with the 
high baseline BDI-II outlier winsorized from 35 to 23. This appears to have done little to reduce bias and the non-normal distribution of 
residuals. Removing the multivariate outlier is therefore justified to reduce substantial bias. 
 
Table 35 
 
Assessment of Bias, Normality, and Generalizability for the Regression Model Predicting Exercise Levels at Follow-Up from BD-II 
(High Score Winsorized), Smoking Status, and HLC Chance (With Multivariate Outlier in Data Set) 
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
LD008 = 3.79 
(p < .001) 
Very unlikely             
                           [X] 
LD008 =1.01 > 1 is 
highest 
 
                           [X] 
 CA065 = 6.03 is 
furthest case from 
centroid. Cutoff = 
11.34  (df=3, p=.01)  
 So OK               []              
CA065 = .17 is 
highest (.33 is 
critical value), so 
OK                     [X] 
LD008= 2.59 
highest for BDI, big 
influence on model 
parameters         [X] 
LD008 = 2.95 much 
> 1, suggests is 
influential case 
                           [X] 
LD008 = .06 Much < 
cutoff (0.67 to 1.33 
ideal) 
JH067 = 1.34    [X] 
 
Durban-Watson Test 
(for independent errors) Residuals Analyses Multicollinearity 
2.17 (values between 1 to 3 
acceptable, so OK) 
                                                      [] 
Histogram:  looks + skewed          [X] 
P-P Plot: abnormal [X]   Zpred Zresid 
heteroscedastic, LD008 outlier    [X] 
 bootstrap 
Greatest Pearson r among predictors (BDI & HLC chance) = .14 (p = .41)    [] 
Tolerance: lowest value = 0.97    VIF: largest value = 1.04                             [] 
Each predictor’s variance proportion is distributed across diff dimensions     [] 
Note. N = 36 [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; + = positive; VIF = variable inflation factor. 
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The bias and normality assessments are presented in Table 36 for the “best” regression model predicting exercise levels at follow-
up. Here, the case of the multivariate outlier was removed from the analysis, but the univariate high baseline BDI-II score was left in 
and continued to exert substantial influence on the regression model. Therefore, winsorizing it would seem justified. 
 
Table 36 
 
Assessment of Bias, Normality, and Generalizability for the Regression Model Predicting Exercise Levels at Follow-Up from BDI-II 
(High Score in), Smoking Status, and HLC Chance (Multivariate Outlier Removed) 
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
JV069 = 2.59 (.010) 
CT018 = -2.43 
(.015) 
Acceptable         [] 
CL029 = .48 < 1 is 
highest 
 
                           [] 
 CL029 = 17.72 is 
furthest case from 
centroid. Cutoff = 
11.34  (df=3, p=.01)  
 So NOT OK      [X]              
CL029 = .52 is 
highest (.33 is 
critical value), so 
much influence  [X] 
CL029 = 1.35 
highest for BDI, 
influence on model 
parameters         [X] 
CL029 = 1.40  > 1, 
suggests is 
influential case 
                           [X] 
CL029 = 2.05 > 
cutoff (0.66 to 1.34 
ideal) 
                           [X] 
 
Durban-Watson Test 
(for independent errors) Residuals Analyses Multicollinearity 
2.01 (values between 1 to 3 
acceptable, so OK) 
                                                      [] 
Histogram:  looks - skewed           [X] 
P-P Plot: abnormal [X]   Zpred Zresid 
heteroscedastic                             [X] 
 bootstrap 
Greatest Pearson r among predictors (BDI & HLC chance) = .11 (p = .52)    [] 
Tolerance: lowest value = 0.98    VIF: largest value = 1.02                             [] 
Each predictor’s variance proportion is distributed across diff dimensions     [] 
Note. N = 35. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; - = negative; VIF = variable inflation factor. 
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Table 37 clearly illustrates that the substantial bias was only improved by both winsorizing the high baseline BDI-II score from 35 
to 23 and removing the multivariate outlier from the data on which the regression analysis for “best” prediction of exercise level at 
follow-up was performed. 
 
Table 37 
 
Assessment of Bias, Normality, and Generalizability for the Regression Model Predicting Exercise Levels at Follow-Up from BDI-II 
(High Score Winsorized), Smoking Status, and HLC Chance (With Multivariate Outlier Removed) 
Standardized 
Residuals Cook’s Distance 
Mahalanobis 
Distance Centered Leverage 
Standardized 
DFBetas Standardized DFFit 
Covariance Ratio 
(Little influence = 
close to 1.0) 
JV069 = 2.57 (.010) 
CT018 = -2.33 
(.020) 
Acceptable         [] 
CT018 = .22 < 1 is 
highest 
 
                           [] 
 CL029 = 9.08 is 
furthest case from 
centroid. Cutoff = 
11.34  (df=3, p=.01)  
 So OK               []              
CL029 = .27 is 
highest (.33 is 
critical value) 
                           [] 
CT018 = 0.82 
highest for HLCc, 
influence on model 
parameters         [] 
CL029 = 1.04  ~ 1, 
Not too influential a 
case 
                           [] 
JV069 = .43 < cutoff 
(0.66 to 1.34 ideal) 
                           [X] 
 
Durban-Watson Test 
(for independent errors) Residuals Analyses Multicollinearity 
2.03 (values between 1 to 3 
acceptable, so OK) 
                                                      [] 
Histogram:  looks neg skewed      [X] 
P-P Plot: abnormal                        [X]    
Zpred Zresid bit heteroscedastic  [X] 
 bootstrap 
Greatest Pearson r among predictors (BDI & bSmoking) = .16 (p = .355)      [] 
Tolerance: lowest value = 0.95   VIF: largest value = 1.05                              [] 
Each predictor’s variance proportion is distributed across diff dimensions     [] 
Note. N = 35. [] = Normal, not cause for concern; [X] = Non-normal, cause for concern; neg = negative; VIF = variable inflation factor. 
 
  
1
4
9
 
Appendix D 
Multiple Imputation Procedure for Missing Values at Follow-Up
  
Eleven out of 36 values (30.56%) for exercise levels at follow-up were missing due 
to participant dropout (n = 8), physical activity diaries that were missing key information 
(n = 2) or diary not submitted (n = 1). SPSS Multiple Imputation procedure was used to 
impute these missing values. The imputation was performed using data that did not include 
the extreme multivariate outlier, as this would have introduced substantial bias. The 
following eight baseline variables were selected to inform the imputation: sex, age, 
smoking status, FEV1/FVC ratio, ESWT distance, BDI-II score, Anxiety Sensitivity Index 
score, MHL Chance scale score. These were chosen based on their relevance as predictors 
of the missing follow-up data and their being key participant characteristics (i.e., age, sex). 
The imputation option we chose was “automatic,” which let SPSS select the imputation 
method best suited for the degree of randomness in the pattern of the missing data. The 
imputation method selected by SPSS was the monotone method, suggesting the data was 
not missing completely at random. (However a missing values analysis including all of 
the variables listed above suggested the data was missing completely at random, as Little’s 
MCAR test was: Chi Square = 9.393, df = 6, p = .153.) Fifteen imputations with a 
maximum of 55 case draws and a maximum of 2 parameter draws were requested. 
Constraints of 0 minimum to 2700 maximum were specified for the follow-up exercise 
levels (MET minute values) to prevent SPSS from producing negative values of MET 
minutes, which would have fallen outside the range of what is possible for level of 
exercise. The maximum value of 2700 was greater than the existing MET minute values 
in the data set. This procedure successfully produced complete follow-up exercise data (N 
= 36). Table 38 below shows the means and standard deviations, and medians and 
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interquartile ranges for the follow-up exercise level data before missing values were 
imputed (n = 25) and after missing values were imputed (N = 36).  
 
Table 38 
Follow-Up Exercise Level Values Before and After Multiple  
Imputation of Missing Values 
         Statistic Mean (SD) Median (IQR) 
Before MI (n = 25)              1062 (838) 933 (510-1623) 
After MI (n = 36)   919 (739) 706 (445-1146) 
Note. SD = standard deviation; IQR = interquartile range; MI = multiple imputation. 
 
 
 
The mean and median values were substantially lower after imputation of the 11 missing 
values. This was expected given that the 8 participants absent at follow-up had higher 
baseline BDI-II scores than those who were present, and tended more to be baseline 
smokers, both of which predicted lower exercise levels at follow-up.  
 
Histograms (Figures 11 and 12) show that the distributions of data before and after 
missing data were imputed are quite similar, thus confirming that imputation did introduce 
much bias. 
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Figure 11. Distribution of follow-up                   Figure 12. Distribution of follow-up 
exercise levels before imputation of       exercise levels after imputation of 
missing data (n = 25).                                              missing data (N = 36). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Appendix E 
Pearson Correlation Table
  
Table 39 
 
Correlation Matrix of Baseline and Outcome Variables 
Variables 
IT 
N=36 
Age 
N=36 
Sex 
N=36 
BMI 
N=36 
Pk/yrs 
N=36 
Smoking 
N=36 
Cohabit 
N=36 
FEV1 % 
N=36 
ESWT Time 
N=36 
BDI 
N=36 
HLC-I 
N=36 
HLC-C 
N=36 
HLC-D 
N=36 
HLC-OP 
N=36 
Attend 
N=36 
Comply 
N=36 
Maint 
N=36 
Maint 
N=35a 
IT                 r 1.00 -.048 .041 -.025 -.264 .250 .000 -.361* -.025 .078 -.160 -.032 -.162 .050 -.274 -.563*** -.130 -.081 
Age              r  1.00 -.125 -.193 .176 -.296 -.393* .331* -.123 -.159 .063 .280 .101 .176 .154 -.044 -.039 -.016 
Sex (F)         r   1.00 .095 -.121 .164 -.532** .220 .067 .272 -.118 .220 -.071 -.116 -.164 .143 -.245 -.359* 
BMI             r    1.00 .045 .075 .026 .309 -.237 -.063 -.068 .038 -.429** .146 .109 -.018 -.161 -045 
Pack/yrs       r     1.00 .014 .023 -.043 -.484** .013 .074 -.104 -.293 .065 .032 .077 -.082 -.078 
Smoking      r      1.00 .250 -.021 -.027 .051 .082 -.106 -.162 -.032 -.034 -.150 -.500** -.512** 
Cohabit        r       1.00 -.299 .007 .039 .086 -.229 -.073 .101 .268 -.104 -.038 .098 
FEV1 %        r        1.00 .235 -.106 .089 .115 -.023 -.032 .439** .054 -.012 -.083 
ESWT, time r         1.00 -.119 -.193 -.094 .153 -.207 .267 .011 .446** .331 
BDI-II          r          1.00 -.127 .118 .104 .026 .018 -.350* -.276 -.515** 
HLC-I          r           1.00 -.058 .549*** .519*** -.012 .090 -.052 -.021 
HLC-C        r            1.00 .006 .182 -.007 -.062 -.318 -.388* 
HLC-D        r             1.00 .189 -.087 .079 .066 .054 
HLC-OP      r              1.00 .247 -.045 -.094 -.083 
Attend         r               1.00 .113 .139 .077 
Comply       r                1.00 .100 .224 
Maintain 36  r                 1.00 . 
Maintain 35 r                  1.00 
Note. IT = interval training, r = Pearson correlation coefficient, BMI = body mass index, Pk/yrs = U.S. pack years, FEV1 % = forced expiratory volume in 1 second 
percent of predicted normal, ESWT = endurance shuttle walking test, BDI = Beck Depression Inventory, HLC-I = health locus on control internal scale, HLC-C = health 
locus of control chance scale, HLC-D = health locus of control doctor scale, HLC-OP = health locus of control other people scale, Attend = PR attendance, Comply = PR 
exercise compliance,  Maintain = exercise levels 9 months post-PR. aOutlier removed.
  
Appendix F 
PR Composite Adherence Data and Analyses
  
Pulmonary rehabilitation (PR) “Composite adherence” refers to a measure 
comprised of attendance at PR exercise sessions and compliance with target intensity 
prescribed for endurance exercise during PR. This measure is the product of PR attendance 
and PR exercise compliance, both equally weighted  (percent of total sessions attended  
percent of total endurance training time exercising to target) for each participant. We 
would argue that attendance alone, the measure consistently reported in the literature on 
PR “adherence” and its predictors, is an inadequate metric of PR adherence, as being 
present does not reflect the extent to which endurance exercise is being performed, which 
is the key component of PR.  As mentioned in the main text of this thesis, compliance 
with exercise, to our knowledge, has not been measured or reported in any previous study 
investigating predictors of engagement in exercise-based PR.  
 
In the present study, PR attendance and PR exercise compliance were both equally 
weighted, however differential weightings could be assigned to each aspect to reflect their 
respective importance. Although determining and then applying differential weightings is 
beyond the scope of the present study, we believe PR attendance takes precedence over 
PR exercise compliance because compliance (in PR) is conditional upon attending. 
Furthermore, if a participant was attending PR but not initially engaging in the physical 
exercise component, their motivation and self-confidence to do so might increase over the 
course of the sessions such that they might begin to engage in exercise. (This would be 
even more likely if the PR program were to include interventions that targeted motivation 
and self-efficacy for exercise.) 
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Composite adherence may have some use in a clinical context in terms of predicting 
or evaluating PR outcomes (i.e., improvements in exercise capacity, dyspnea, health-
related quality of life, and frequency/severity of COPD exacerbations), but it was not a 
main focus in meeting this study’s objectives, as more information could be gleaned from 
examining PR attendance and exercise compliance (and their distinct predictors) 
separately. The composite measure alone does not allow for an analyses or appreciation 
of its component parts or their distinct predictor variables and therefore does not inform 
with which aspect of PR a participant may be having difficulty (i.e., attendance or exercise 
compliance or both) nor what the focus of an intervention to help improve PR adherence 
should be. Nevertheless, we present in this appendix the correlation and multiple 
regression analyses conducted on baseline depression symptoms (our predictor of interest) 
and composite adherence in the context of the same selected covariates included in the 
regressions conducted on the separate outcomes to show what emerges.  
 
The median percent (IQR) PR composite adherence score for our sample is 72 (29–
86) and the mean percent (SD) was 57 (33). The distribution of PR composite adherence 
scores for our sample is presented in Figure 13 below and reveals a somewhat bimodal 
pattern with grouping of several participants with low adherence and others with high 
adherence. Figure 14 illustrates the relationship between baseline BDI-II and PR 
composite adherence. Baseline depressive symptomatology does not predict composite 
adherence (at least not significantly). The Pearson correlation is negative and weak when 
the outlying high BDI-II score is retained in the data set (r = -.27, p = .116) and weaker 
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when it is winsorized from 35 to 23 (r = -.22, p = .196). When the outlying BDI-II score 
is kept in, variation in BDI-II accounts for only 7.3 % of variation in composite adherence 
and this decreases to 4.8 % when the outlier is winsorized. We know from the correlation 
analyses run on each separate component of composite adherence that it is the negative 
association between baseline depression and PR exercise compliance that drives the weak 
association between baseline BDI-II and composite adherence. 
 
                    
Figure 13. Distribution of PR                           Figure 14. Relationship between baseline 
composite adherence (N = 36).                          depression and PR composite adherence  
                                                                           (N = 36, Pearson r = -. 27, p = .116). 
 
 
 
Table 40 below presents the results of the multiple linear regression analysis with 
baseline BDI-II as the predictor of interest and PR composite adherence as the outcome 
in the context of selected covariates. Interval training is the only variable that emerged as 
a significant predictor of lower composite adherence (IT was the hardest and most 
demanding for participants). We know from the regression analyses performed on each 
component of composite adherence that IT was not a significant predictor or PR 
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attendance (though there was a weak negative signal there), but was a strong predictor of 
poor PR exercise compliance. So its emergence as a predictor of composite adherence is 
driven mainly by the correlation between IT and PR exercise compliance, not PR 
attendance. 
 
 
Table 40 
 
Multiple Linear Regression Model for Prediction of PR Composite Adherence  
from Baseline BDI-II and Selected Covariates 
  Bootstrapa 
Variable     B         ß          SE B p 95 % CI for Bb 
Constant 80.43  27.30 .008 [26.85, 140.92] 
bBDI-II -1.45 -.24   0.98 .162 [-3.27, 0.35] 
IT -41.52 -.60 14.40 .014 [-68.14, -15.44] 
CTHi -4.55 -.07 11.99 .727 [-30.11, 18.92] 
Sex (F)   9.96 .15  11.43 .401 [-10.51, 29.81] 
bFEV1 %   0.02 .01   0.35 .953 [-0.59, 0.66] 
bSmoking  -6.08 -.09 10.26 .561 [-27.92, 15.23] 
Regression Model        R = .65        Adjusted R2 = .30        F (6, 29) = 3.47, p = .011 
Note. N = 36. CI = confidence interval; bBDI-II = baseline Beck Depression Inventory-II; IT = 
interval training; CTHi = constant training high intensity; bFEV1 % = baseline forced expiratory 
volume in the first second percent of predicted normal value; bSmoking = smoking at baseline. 
aBootstrap results are based on 1000 bootstrap samples. bConfidence intervals are bias-corrected 
and accelerated. 
 
 
Interval training is the only variable that emerged as a significant predictor of lower 
composite adherence (IT was the hardest and most demanding for participants). We know 
from the regression analyses performed on each component of composite adherence that 
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IT was not a significant predictor or PR attendance (though there was a weak 
negative signal there), but was a strong predictor of poor PR exercise compliance. So its 
emergence as a predictor of composite adherence is driven mainly by the correlation 
between IT and PR exercise compliance, not PR attendance.  
